aculife healthcare 1 firm remarks: may be...
TRANSCRIPT
S No FirmsItem
CodeSpecification Item Remarks Status
1ACULIFE HEALTHCARE
PRIVATE LIMITED
1 95
Ciprofloxacin Injection IP 200mg/100ml BFS /
FFS May be considered
2 224
Dextrose with Sodium Chloride Injection 5% +
0.9% IP in 500ml IV BFS / FFS May be considered
3 440 Metronidazole IV Infusion IP 500mg in 100 ml May be considered
The firm has not submitted the product approval May not be
Statement showing the Firm wise Technical Bid Evaluation Report for General Medicines
Tender Notice No: 60(20-21)/APMSIDC/Medicine Wing/2020-22, Dated: 03.06.2020
Firm Remarks: May be Considered
4 655 Water for Injection IP 10 ml amp
The firm has not submitted the product approval
for this product.
May not be
considered
5 1304 Lipids I.V. 20% In 250ml Bottles May be considered
6 1639
Mannitol 20% I.V. Infusion IP 100ml bottle
BFS/FFS May be considered
7 1676
Hydroxyethyl starch BP ( Hetastarch) with 450K
dalton/Tetra starch Hydroxyethyl starch 130K
dalton molecular weight May be considered
8 2119
Paracetamol Solution for Infusion (10mg/ml) in
100ml glass bottle i.e.1gm/100ml BFS/FFS May be considered
9 2262 Dextrose 10% I.V 500 ml May be considered
2 ADHISH INDUSTRIES
1 1366 Chlorine Tablets 0.5gm May be considered
Firm Remarks: Avg turn over is less then as per tender hence May not be considered. And NCC certificate not submitted.
1 1366 Chlorine Tablets 0.5gm May be considered
3ADLEYFORMULATION
SPVTLTD
1 1220 Doxorubicin Injection IP 10 mg / 5 ml May be considered
2 1267 Cisplatin Injection IP 10 mg / 10 ml vial May be considered
3 1799 Etoposide Injection 100 mg / 5 ml vial May be considered
Firm Remarks: Firm may be considered after submission of Shelf life details of the all quoted products.
Page 1 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
4 1907 Paclitaxel Injection IP 30 mg / 5 ml May be considered
5 2098 Imatinib Mesylate Tab 400mg(Addl. Indication) May be considered
6 2227 Calcium Leucovorin Injection 50mg/ 5 ml vial May be considered
7 2233 Carboplatin 150mg /15 ml Injection Vial May be considered
8 2234 Carboplatin 450mg / 45 ml Injection Vial May be considered
9 2242 Cisplatin Injection IP 50 mg / 10 ml vial
May not be considered as the
specification/Strength is not matched
May not be
considered9 2242 Cisplatin Injection IP 50 mg / 10 ml vial specification/Strength is not matched considered
10 2269
Docetaxel 20mg/5ml or 20 mg/0.5 ml fill volume
in 5 ml vial May be considered
11 2270 Docetaxel 80mg/ 2 ml vial May be considered
12 2276
Each 20ml of reconstituted suspension contains:
Paclitaxel, USP-100mg Albumin Human USP-900
mg
May not be considered as the
specification/Strength is not matched
May not be
considered
13 2279 Erlotinib Tablets 150mg May be considered
14 2300 Gemcitabine 200mg Injection vial May be considered
15 2305 Hydroxy Urea Capsules 500mg May be considered
16 2372 Oxaliplatin 100mg Injection vial May be considered
17 2373 Oxaliplatin 50mg Injection vial May be considered
18 2374 Paclitaxel Injection 260mg vial May be considered
4 ADMAC LIFESCIENCES
1 1220 Doxorubicin Injection IP 10 mg / 5 ml May be considered
2 1267 Cisplatin Injection IP 10 mg / 10 ml vial
May be considered after submission of valid
product approval as per tender requirement.
May not be
considered
Firm Remarks: May be Considered
Page 2 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
3 1799 Etoposide Injection 100 mg / 5 ml vial May be considered
4 1907 Paclitaxel Injection IP 30 mg / 5 ml May be considered
5 2098 Imatinib Mesylate Tab 400mg(Addl. Indication) May be considered
6 2233 Carboplatin 150mg /15 ml Injection Vial May be considered
7 2234 Carboplatin 450mg / 45 ml Injection Vial May be considered
8 2242 Cisplatin Injection IP 50 mg / 10 ml vial May be considered8 2242 Cisplatin Injection IP 50 mg / 10 ml vial May be considered
9 2269
Docetaxel 20mg/5ml or 20 mg/0.5 ml fill volume
in 5 ml vial May be considered
10 2270 Docetaxel 80mg/ 2 ml vial May be considered
11 2279 Erlotinib Tablets 150mg May be considered
12 2300 Gemcitabine 200mg Injection vial May be considered
13 2372 Oxaliplatin 100mg Injection vial May be considered
14 2373 Oxaliplatin 50mg Injection vial May be considered
15 2374 Paclitaxel Injection 260mg vial May be considered
5
Adroit
Pharmaceuticals Pvt Firm Remarks: May be Considered5 Pharmaceuticals Pvt
Limited
1 193 Dicyclomine Hcl Tablets 10 mg May be considered
2 279 Folic Acid Tablets 5mg May be considered
3 285 Formaldehyde Solution 500ml bottle
May be considered after submission of valid
product approval as per tender requirement.
May not be
considered
4 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle May be considered
Firm Remarks: May be Considered
Page 3 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
5 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
6 525 Paracetamol Tablets IP 500 mg May be considered
7 1137 Domperidone Tablets IP 10 mg May be considered
8 1162 Loperamide Tablets 2mg May be considered
9 1177 Hydrogen Peroxide Solution IP 6% in 200ml
May be considered after submission of valid
product approval as per tender requirement.
May not be
considered
10 1521 Primaquine Tablets IP 2.5 mg May be considered10 1521 Primaquine Tablets IP 2.5 mg May be considered
11 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
12 1636 Isoxsuprine Hcl Tablets 10 mg May be considered
13 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
14 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
15 1665 Glycerin IP 450gm May be considered
16 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
17 2367 Oint.Salicylic Acid IP 6.0% w/w 30 grms tube May be considered
6
Akums Drugs &
pharmaceuticals Firm Remarks: May be Considered6 pharmaceuticals
Limited
1 95
Ciprofloxacin Injection IP 200mg/100ml BFS /
FFS May be considered
2 440 Metronidazole IV Infusion IP 500mg in 100 ml May be considered
3 605 Ranitidine Hcl (Film Coated) Tablets IP 150 mg May be considered
4 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
Firm Remarks: May be Considered
Page 4 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
5 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
6 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml May be considered
7 1639
Mannitol 20% I.V. Infusion IP 100ml bottle
BFS/FFS May be considered
8 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
9 1650 Permethrin Cream 5% 30gms tube May be considered
10 1678 Methyl Cobalamin Tablets 500mcg May be considered10 1678 Methyl Cobalamin Tablets 500mcg May be considered
11 1699 Azithromycin Dispersible Tablet 100 Mg May be considered
12 1700 Meropenam Injection IP 1gm vial May be considered
13 1865 Mefenamic Acid Tablets BP 500 mg May be considered
14 1970 Tranexamic acid Tablets BP 250mg May be considered
15 2073 Citicoline Tab 500mg May be considered
16 2113 Montelukast Tab 10mg May be considered
17 2119
Paracetamol Solution for Infusion (10mg/ml) in
100ml glass bottle i.e.1gm/100ml BFS/FFS May be considered
18 2217 Betahistine Tablets IP 16 mg May be considered
19 2325 Levofloxacin Tablet 500 mg May be considered
20 2326 Levofloxacin Tablet 750 mg May be considered
21 2352
Natural Progesterone Injection 100mg/2 ml 2ml
Ampule May be considered
22 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
Page 5 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
23 2398 Quetiapine 50mg Tablet May be considered
24 2437 Trypsin and Chymotrypsin Tablets 10 mg May be considered
7
ALCON
LABORATORIES INDIA
PRIVATE LIMITED
1 2304
Hydroxy Propyl Methyl Cellulose Eye Drops 0.3%
in 10 ml May be considered
8Alpa Laboratories
Limited
Firm Remarks: May be Considered
Firm Remarks: May be Considered8Limited
1 527.01 Paracetamol Injection 300mg in 2ml
May be considered after submission of latest
product validity license
May not be
considered
2 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
3 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp
May be considered after submission of latest
product validity license
May not be
considered
4 1700 Meropenam Injection IP 1gm vial
May be considered after submission of latest
product validity license
May not be
considered
5 2066 Atropine sulphate injection 0.6%, 10ml vials
May be considered after submission of latest
product validity license
May not be
considered
6 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
9ANGLIFESCIENCES I
PVT LTD
1 664 Thiopentone Sodium Injection IP 0.5gm /ml May be considered
Firm Remarks: May be Considered
Firm Remarks: May be Considered
1 664 Thiopentone Sodium Injection IP 0.5gm /ml May be considered
2 1310
Methyl Prednesolone Sodium Succinate Injection
USP 500 mg May be considered
3 1479 Acyclovir Injection 250mg May be considered
4 1700 Meropenam Injection IP 1gm vial May be considered
5 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
Page 6 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
10Appasamy Ocular
Devices (P) Ltd.
1 1372 Tropicamide+ phenylephrine 5 ml Eye drops May be considered
2 1377 Flurbiprofen Eye drops BP 0.03% 5 ml May be considered
3 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial May be considered
4 1742
Balanced Salt Solution Ophthalmic Solution 500
ml Pouch May be considered
5 1905 Olopatadine eye drops 0.1%w/v May be considered
Firm Remarks: May be Considered
5 1905 Olopatadine eye drops 0.1%w/v May be considered
6 1967 Tobramycin Eye drops 0.3% in 5 ml vial May be considered
7 2255 Cyclo Pentolate Eye drops 1% 5ml May be considered
8 2304
Hydroxy Propyl Methyl Cellulose Eye Drops 0.3%
in 10 ml May be considered
9 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial May be considered
10 2389 Povidone Iodine Eye Drops 5%, 5ml Vial May be considered
11 2434 Timolol Maleate eye Drops IP 0.5%, 5 ml May be considered
11ARCO LIFESCIENCES
INDIA PVT LTD
1 107
Chloroquine Phosphate Injection IP 40 mg / ml in
3ml amp May be considered
Firm Remarks: May be Considered
1 107 3ml amp May be considered
2 209
Dopamine Hcl Injection IP 200mg in 5ml vial and
ampoule
May be considered after clarification of strength.
Submitted product approval for 40mg/ml whereas
in tender asked for 200mg/5ml
May not be
considered
3 266 Furosemide Injection , IP 10mg/1ml in 2 ml amp May be considered
4 714
Menadione Sodium Bisulphate Inj 10mg/ml 1ml
Amp USP May be considered
Page 7 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
5 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml
May be considered after clarification of strength.
Submitted product approval for 50mg whereas in
tender asked for 100mg/ml
May not be
considered
6 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered
7 2066 Atropine sulphate injection 0.6%, 10ml vials May be considered
8 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
9 2319
Ketorolac Tromethamine Injection 30mg /ml, 1 ml
Ampoule May be considered
10 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules
May be considered after clarification of strength.
Submitted product approval for 2mg whereas in
tender asked for 1mg/ml,2ml.
May not be
considered
11 2388
Potassium Chloride Injection 150mg/ml,10ml
Ampoule May be considered
12
ATRA
PHARMACEUTICALS
LIMITED
1 106
Chloroquine Phosphate Tablets IP 250 mg
base(Equivalent to 155 mg of Chloroquine ) May be considered
2 525 Paracetamol Tablets IP 500 mg May be considered
3 1470 Oseltamivir Cap 75mg May be considered
4 2325 Levofloxacin Tablet 500 mg May be considered
Firm Remarks: May be Considered
4 2325 Levofloxacin Tablet 500 mg May be considered
13 Aurolab
1 1372 Tropicamide+ phenylephrine 5 ml Eye drops
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered
2 1377 Flurbiprofen Eye drops BP 0.03% 5 ml
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered
Firm Remarks: May be Considered
Page 8 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
3 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered
4 1683
Triamcinalone acetate Injection IP 40mg/ml 1ml
vial
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered
5 1819 Homatropine eye Drops IP 2% 5 ml
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered5 1819 Homatropine eye Drops IP 2% 5 ml after submission of latest product approval list. considered
6 1948
Silicon Oil Injection 1000mm 2/5 (cst) Injection
10ml Vial
Not submitted Approved product list hence May
not be considered
May not be
considered
7 2255 Cyclo Pentolate Eye drops 1% 5ml
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered
8 2389 Povidone Iodine Eye Drops 5%, 5ml Vial
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered
9 2434 Timolol Maleate eye Drops IP 0.5%, 5 ml
Bidder has submitted retension certificate of Form
28 valid upto 10-12-2022. May be considered
after submission of latest product approval list.
May not be
considered
14BAXALTA BIOSCIENCE
INDIA PVT LTDFirm Remarks: May be Considered14
INDIA PVT LTD
1 1367 Human Albumin Solution I.P. 20% in100 ml bottle May be considered
2 2208
Anti Inhibitor Coagulant Complex (Intravenous
Route) 500 IU vial May be considered
3 2250
Coagulation Factor VIII rF VIII ( Recombinant or
Freeze Dried ) 1000 IU May be considered
Firm Remarks: May be Considered
Page 9 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
4 2251
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried) 1500 IU
The firm has registration till 30/9/2018 for this
strength, after that period applicant failed to
enclose latest approval.
May not be
considered
5 2252
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried ) 250 IU May be considered
15BAXTERINDIAPRIVATE
LIMITED
1 1742
Balanced Salt Solution Ophthalmic Solution 500
ml Pouch
May be considered after submission of valid
product approval latest as per tender
requirement.
May not be
considered
16Bharat Serums And
Vaccines Ltd
Firm Remarks: May be Considered
Firm Remarks: May be Considered16Vaccines Ltd
1 632 Antisnake Venom Injection May be considered
17bharath parentals
limeted
1 8
Amoxicillin oral suspension IP 125 mg / 5 ml in
60ml May be considered
2 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
3 192 Doxycycline HCL Capsule IP 100 mg May be considered
4 209
Dopamine Hcl Injection IP 200mg in 5ml vial and
ampoule
Submitted dosage strength is of 40mg where as in
tender asked for 200mg.
May not be
considered
5 279 Folic Acid Tablets 5mg May be considered
6 525 Paracetamol Tablets IP 500 mg May be considered
Firm Remarks: May be Considered
6 525 Paracetamol Tablets IP 500 mg May be considered
7 714
Menadione Sodium Bisulphate Inj 10mg/ml 1ml
Amp USP May be considered
8 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
9 1218
Dobutamine Hcl For Injection USP 250mg / 20 ml
Vial
Submitted dosage strength is of 12.50mg where
as in tender asked for 250mg/20ml vial.
May not be
considered
10 1310
Methyl Prednesolone Sodium Succinate Injection
USP 500 mg May be considered
Page 10 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
11 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
12 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
13 1340
Amoxycillin 500mg + 125mg Potassium Clavulanic
Acid Tablets IP May be considered
14 1370
Vitamin A Paediatric retinol solution 100000 IU
per ml May be considered
15 1426 Clotrimazole Ear Drops 1% in 5ml vial
Submitted packing is 10ml whereas in tender
asked for 5ml vial.
May not be
considered
16 1521 Primaquine Tablets IP 2.5 mg May be considered16 1521 Primaquine Tablets IP 2.5 mg May be considered
17 1621 Cefixime Dispersible Tablets USP 100 mg As it is for Export purpose only
May not be
considered
18 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
19 1629 Fluconazole Tablets IP 200mg As it is for Export purpose only
May not be
considered
20 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle
Submitted dosage strength is of 10gm where as in
tender asked for 3.325gm.
May not be
considered
21 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
22 1700 Meropenam Injection IP 1gm vial May be considered
23 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
24 1739 Atorvastatin Tablets IP 20mg May be considered
25 1903 Olanzapine Tablets 5 mg May be considered
26 1953 Sodium valporate Tablets IP 200mg May be considered
27 1967 Tobramycin Eye drops 0.3% in 5 ml vial May be considered
28 2065 Atorvastatin Tablets IP 10mg May be considered
29 2069 Carbmazepine Tablets 200mg May be consideredPage 11 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
30 2073 Citicoline Tab 500mg As it is for Export purpose only
May not be
considered
31 2080 Diclofenac Sodium Tablets 100mg SR As it is for Export purpose only
May not be
considered
32 2140 Sodium Valporate Tab 500mg May be considered
33 2227 Calcium Leucovorin Injection 50mg/ 5 ml vial
Submitted product strength is 10mg/ml whereas
in tender asked for 50mg/5ml
May not be
considered
34 2235
Cefixime oral suspension 100mg / 5ml in 60ml
Bottle As it is for Export purpose only
May not be
considered
35 2243 Clindamycin 1 % gel 30 gms May be considered35 2243 Clindamycin 1 % gel 30 gms May be considered
36 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
37 2293 Fluoxetine Capsule 20mg May be considered
38 2325 Levofloxacin Tablet 500 mg May be considered
39 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
40 2412 Rosuvastatin Calcium 20 mg Tablet As it is for Export purpose only
May not be
considered
41 2440 Zinc Sulphate Dispersible Tablet10mg As it is for Export purpose only
May not be
considered
18 Biological E. Limited
1 632 Antisnake Venom Injection May be considered
Japanese Encephalitis Vaccine, Inactivated
Firm Remarks: May be Considered
2 2318
Japanese Encephalitis Vaccine, Inactivated
(Absorbed, Human) IP 0.5ml vial May be considered
19
CADILA
PHARMACEUTICALS
LIMITED
1 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
2 525 Paracetamol Tablets IP 500 mg May be considered
Firm Remarks: May be Considered
Page 12 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
3 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
4 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered
5 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle
Firm has no product license approval for this
strenght.
May not be
considered
6 1683
Triamcinalone acetate Injection IP 40mg/ml 1ml
vial May be considered
7 1739 Atorvastatin Tablets IP 20mg May be considered
8 2325 Levofloxacin Tablet 500 mg May be considered8 2325 Levofloxacin Tablet 500 mg May be considered
20
CENTURY
PHARMALABS INIDA
PRIVATE LIMITED
1 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
2 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
3 1650 Permethrin Cream 5% 30gms tube May be considered
4 2243 Clindamycin 1 % gel 30 gms May be considered
5 2244
Clindamycin 1% w/w + Benzoyl Peroxide 2.5 w/w
15 gms May be considered
21CIAN HEALTHCARE
LIMITED
May be considered after submission of latest May not be
Firm Remarks: May be Considered
Firm Remarks: May be Considered
1 192 Doxycycline HCL Capsule IP 100 mg
May be considered after submission of latest
product approval
May not be
considered
2 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
3 201 Diethylcarbamazine Citrate Tablets IP 100mg May be considered
4 265 Furosemide Tablets IP 40mg May be considered
5 279 Folic Acid Tablets 5mg May be considered
Page 13 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 525 Paracetamol Tablets IP 500 mg May be considered
7 1134 Risperidone Tablets USP 2 mg May be considered
8 1137 Domperidone Tablets IP 10 mg May be considered
9 1162 Loperamide Tablets 2mg May be considered
10 1254 Spironolactone Tablets IP 25 mg, May be considered
11 1317 Ondansetron Tablets IP 4 mg May be considered11 1317 Ondansetron Tablets IP 4 mg May be considered
12 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
13 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
14 1629 Fluconazole Tablets IP 200mg May be considered
15 1636 Isoxsuprine Hcl Tablets 10 mg May be considered
16 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle May be considered
17 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
18 1650 Permethrin Cream 5% 30gms tube May be considered
19 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
20 1691 Aciclovir Tablets IP 400 mg May be considered
21 1699 Azithromycin Dispersible Tablet 100 Mg May be considered
22 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered
23 1734 Allopurinol Tablets IP 100 mg May be considered
24 1739 Atorvastatin Tablets IP 20mg May be consideredPage 14 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
25 1794 Escitalopram Tablets 10mg May be considered
26 1808 Flunarazine Tablets 5mg May be considered
27 1855 Levamisole Tablets IP 150mg May be considered
28 1865 Mefenamic Acid Tablets BP 500 mg May be considered
29 1866 Mefloquine Hcl IP Tablets 250mg May be considered
30 1903 Olanzapine Tablets 5 mg May be considered30 1903 Olanzapine Tablets 5 mg May be considered
31 1970 Tranexamic acid Tablets BP 250mg May be considered
32 2065 Atorvastatin Tablets IP 10mg May be considered
33 2073 Citicoline Tab 500mg May be considered
34 2113 Montelukast Tab 10mg May be considered
35 2125 Prazosin Tab 5mg May be considered
36 2126 Pregabalin SR Tablet 75mg May be considered
37 2163 Verapamil Tab 40mg May be considered
38 2164 Verapamil Tab 80mg May be considered
39 2205 Amitriptyline Tablets 25mg May be considered
40 2243 Clindamycin 1 % gel 30 gms May be considered
41 2258 Deflozocort Tablets 6mg May be considered
42 2271 Donepezil Tablets 5mg May be considered
43 2281 Escitalopram Tablets 5mg May be consideredPage 15 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
44 2292 Flunarizine Tablets 10mg May be considered
45 2293 Fluoxetine Capsule 20mg May be considered
46 2313 Isosorbide Dinitrate Tablets 10mg May be considered
47 2316 Itraconazole Capsule 100 mg May be considered
48 2317 Ivermectin Tablets USP 6mg May be considered
49 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered49 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered
50 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle May be considered
51 2325 Levofloxacin Tablet 500 mg May be considered
52 2339 Mebeverine Hydrochloride IP 135mg Tablet May be considered
53 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
54 2483 CilnidipineTab 20mg May be considered
55 2484 Prazocin Tab 1mg May be considered
56 2494 Chlorthalidone Tab 6.25mg May be considered
22Concord Biotech
LimitedFirm Remarks: May be Considered
1 1888 Mycophenolate mofetil Tab 500mg May be considered
2 1959 Tacrolimus Capsules 1mg May be considered
23 Coral Laboratories Ltd
1 37 Atenolol Tablets IP 50mg
May be considered after submission of latest valid
product license
May not be
considered
2 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole )
May be considered after submission of latest valid
product license
May not be
considered
Firm Remarks: May be considered after submission of valid product approval license for form-25 and Annexure-VIII with full address
Page 16 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
3 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg
May be considered after submission of latest valid
product license
May not be
considered
4 106
Chloroquine Phosphate Tablets IP 250 mg
base(Equivalent to 155 mg of Chloroquine )
May be considered after submission of latest valid
product license
May not be
considered
5 192 Doxycycline HCL Capsule IP 100 mg
May be considered after submission of latest valid
product license
May not be
considered
6 193 Dicyclomine Hcl Tablets 10 mg
May be considered after submission of latest valid
product license
May not be
considered
7 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets)
May be considered after submission of latest valid
product license
May not be
considered
8 207 Diltiazem Tablets IP 30 mg
May be considered after submission of latest valid
product license
May not be
considered8 207 Diltiazem Tablets IP 30 mg product license considered
9 251 Enalapril Maleate Tablets IP 5mg
May be considered after submission of latest valid
product license
May not be
considered
10 265 Furosemide Tablets IP 40mg
May be considered after submission of latest valid
product license
May not be
considered
11 279 Folic Acid Tablets 5mg
May be considered after submission of latest valid
product license
May not be
considered
12 482 Norfloxacin Tablets IP 400mg
May be considered after submission of latest valid
product license
May not be
considered
13 525 Paracetamol Tablets IP 500 mg
May be considered after submission of latest valid
product license
May not be
considered
14 564.01 Promethazine Hcl Syrup IP 5 mg / 5 ml in 60ml
May be considered after submission of latest valid
product license
May not be
considered
15 577 Prednesolone Tab 10mg
May be considered after submission of latest valid
product license
May not be
considered
16 605 Ranitidine Hcl (Film Coated) Tablets IP 150 mg
May be considered after submission of latest valid
product license
May not be
considered
17 1137 Domperidone Tablets IP 10 mg
May be considered after submission of latest valid
product license
May not be
considered
18 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle
May be considered after submission of latest valid
product license
May not be
considered
19 1254 Spironolactone Tablets IP 25 mg,
May be considered after submission of latest valid
product license
May not be
considered
20 1319 Pantaprazole (Enteric Coated) Tablets 40mg
May be considered after submission of latest valid
product license
May not be
considered
21 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated)
May be considered after submission of latest valid
product license
May not be
consideredPage 17 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
22 1340
Amoxycillin 500mg + 125mg Potassium Clavulanic
Acid Tablets IP
May be considered after submission of latest valid
product license
May not be
considered
23 1438
Levothyroxine Tablets IP 100 micrograms(un
coated)
May be considered after submission of latest valid
product license
May not be
considered
24 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml Produced product approval for syrup
May not be
considered
25 1705 Alprazolam Tablets IP 0.5 mg
May be considered after submission of latest valid
product license
May not be
considered
26 1734 Allopurinol Tablets IP 100 mg
May be considered after submission of latest valid
product license
May not be
considered
27 1739 Atorvastatin Tablets IP 20mg
May be considered after submission of latest valid
product license
May not be
considered27 1739 Atorvastatin Tablets IP 20mg product license considered
28 1903 Olanzapine Tablets 5 mg
May be considered after submission of latest valid
product license
May not be
considered
29 2062 Acetyl Salicylic acid Tablets IP 75mg
May be considered after submission of latest valid
product license
May not be
considered
30 2069 Carbmazepine Tablets 200mg
May be considered after submission of latest valid
product license
May not be
considered
31 2080 Diclofenac Sodium Tablets 100mg SR
May be considered after submission of latest valid
product license
May not be
considered
32 2111 Levothyroxine Tablets 50mcg
May be considered after submission of latest valid
product license
May not be
considered
33 2325 Levofloxacin Tablet 500 mg
May be considered after submission of latest valid
product license
May not be
considered
24Cyano Pharma Private
Limited
1 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets)
May be considered after submission of latest valid
product license.
May not be
considered
Firm Remarks: May be considered after submission of Product License validity and latest product approval list.
1 197 Tablets) product license. considered
2 279 Folic Acid Tablets 5mg
May be considered after submission of latest valid
product license.
May not be
considered
3 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle
May be considered after submission of latest valid
product license.
May not be
considered
4 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream
May be considered after submission of latest valid
product license.
May not be
considered
5 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml
May be considered after submission of latest valid
product license.
May not be
considered
6 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream
May be considered after submission of latest valid
product license.
May not be
consideredPage 18 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
7 1653 Povidone Iodine Ointment USP IP 5%, 100gm
May be considered after submission of latest valid
product license.
May not be
considered
8 1739 Atorvastatin Tablets IP 20mg
May be considered after submission of latest valid
product license.
May not be
considered
9 2065 Atorvastatin Tablets IP 10mg
May be considered after submission of latest valid
product license.
May not be
considered
10 2440 Zinc Sulphate Dispersible Tablet10mg
May not be considered as the
specification/Strength is not matched
May not be
considered
25
Daffodills
Pharmaceticals
LimitedCotrimaxazole Tabs. IP 160mg+800mg
Firm Remarks: May be Considered
1 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
2 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg May be considered
3 192 Doxycycline HCL Capsule IP 100 mg May be considered
4 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
5 209
Dopamine Hcl Injection IP 200mg in 5ml vial and
ampoule May be considered
6 211 Etophylline 77mg + Theophylline 23mg Tablets IP May be considered
7 265 Furosemide Tablets IP 40mg May be considered
8 266 Furosemide Injection , IP 10mg/1ml in 2 ml amp May be considered
Gamma Benzene Hexachloride Lotion 1% in 60ml
9 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle May be considered
10 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
11 482 Norfloxacin Tablets IP 400mg May be considered
12 525 Paracetamol Tablets IP 500 mg May be considered
13 527.01 Paracetamol Injection 300mg in 2ml May be considered
Page 19 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
14 714
Menadione Sodium Bisulphate Inj 10mg/ml 1ml
Amp USP Firm has not submitted the product approval
May not be
considered
15 753 Povidone Iodine Solution 5% , 500ml bottle May be considered
16 1137 Domperidone Tablets IP 10 mg May be considered
17 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered
18 1426 Clotrimazole Ear Drops 1% in 5ml vial May be considered
19 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml
May be considered after submission of 10ml
product approval.
May not be
considered19 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml product approval. considered
20 1462 Ethamsylate Injection125mg/ml 2 ml ampoule May be considered
21 1479 Acyclovir Injection 250mg May be considered
22 1623 Chloramphenicol Ear drops IP 5ml May be considered
23 1626
Chlorpheniramine Maleate Syrup 2 mg / 5ml in
60ml bottle May be considered
24 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
25 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
26 1650 Permethrin Cream 5% 30gms tube May be considered
27 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
28 1700 Meropenam Injection IP 1gm vial Firm has not submitted the product approval
May not be
considered
29 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered
30 2243 Clindamycin 1 % gel 30 gms May be considered
31 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
32 2316 Itraconazole Capsule 100 mg May be consideredPage 20 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
33 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle Firm has not submitted the product approval
May not be
considered
34 2325 Levofloxacin Tablet 500 mg Firm has not submitted the product approval
May not be
considered
35 2383 Piperacillin + tazobactum Injection 2gm +0.25gm Firm has not submitted the product approval
May not be
considered
36 2388
Potassium Chloride Injection 150mg/ml,10ml
Ampoule May be considered
26 Denis Chemlab ltd
1 95
Ciprofloxacin Injection IP 200mg/100ml BFS /
FFS May be considered
Dextrose with Sodium Chloride Injection 5% +
Firm Remarks: May be Considered
2 224
Dextrose with Sodium Chloride Injection 5% +
0.9% IP in 500ml IV BFS / FFS May be considered
3 440 Metronidazole IV Infusion IP 500mg in 100 ml May be considered
4 2119
Paracetamol Solution for Infusion (10mg/ml) in
100ml glass bottle i.e.1gm/100ml BFS/FFS May be considered
5 2212 Atropine sulphate injection 0.6%, 100ml vial
May be considered after submission of latest
approved product license as per tender
requirement.
May not be
considered
6 2262 Dextrose 10% I.V 500 ml May be considered
27Drreddyslaboratoriesli
mited
1 251 Enalapril Maleate Tablets IP 5mg May be considered
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
Firm Remarks: May be Considered
2 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
3 1739 Atorvastatin Tablets IP 20mg May be considered
4 1930 Ramipril Tablets IP 5mg
Submitted product approval is for Capsules where
as in tender asked for tablets. May be considered
after clarification.
May not be
considered
5 2065 Atorvastatin Tablets IP 10mg May be considered
Page 21 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 2319
Ketorolac Tromethamine Injection 30mg /ml, 1 ml
Ampoule May be considered
7 2339 Mebeverine Hydrochloride IP 135mg Tablet May be considered
8 2342 Mesalazine Tablet 1.2 gm May be considered
28DUEFUL HEALTHCARE
PVT LTD
1 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
Firm Remarks: May be Considered
2 1700 Meropenam Injection IP 1gm vial May be considered
29
EMCURE
PHARMACEUTICALS
LIMITED
1 1888 Mycophenolate mofetil Tab 500mg May be considered
2 1959 Tacrolimus Capsules 1mg May be considered
30ESKAG PHARMA PVT
LTD
1 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle
May not be considered as the composition is not
matched as per the tender requirement.
May not be
considered
31FARISTA VANIJYA
PRIVATE LIMITED
Ciprofloxacin Injection IP 200mg/100ml BFS /
Firm Remarks: May be cosidered after submission of Drug Manufacturing license( Whole Copy)
Firm Remarks: May be considered after submission of Valid NCC certificate (not older then 6 months), Valid GMP/WHO-GMP
certificate and list of latest valid approved product licenses.
Firm Remarks: May be Considered
1 95 FFS May be considered
2 224
Dextrose with Sodium Chloride Injection 5% +
0.9% IP in 500ml IV BFS / FFS
May be considered after submission of valid
product approval as per tender requirement.
May not be
considered
3 440 Metronidazole IV Infusion IP 500mg in 100 ml May be considered
4 1639
Mannitol 20% I.V. Infusion IP 100ml bottle
BFS/FFS May be considered
Page 22 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
32
FINECURE
PHARMACEUTICALS
LIMTED
1 1340
Amoxycillin 500mg + 125mg Potassium Clavulanic
Acid Tablets IP May be considered
2 2325 Levofloxacin Tablet 500 mg May be considered
3 2326 Levofloxacin Tablet 750 mg May be considered
33FRESENIUS KABI
INDIA PVT LTD
Firm Remarks: May be Considered
Firm Remarks: May be Considered
1 1304 Lipids I.V. 20% In 250ml Bottles May be considered
2 1676
Hydroxyethyl starch BP ( Hetastarch) with 450K
dalton/Tetra starch Hydroxyethyl starch 130K
dalton molecular weight May be considered
3 2119
Paracetamol Solution for Infusion (10mg/ml) in
100ml glass bottle i.e.1gm/100ml BFS/FFS May be considered
34FRESENIUS KABI
ONCOLOGY LIMITED
1 1220 Doxorubicin Injection IP 10 mg / 5 ml May be considered
2 1907 Paclitaxel Injection IP 30 mg / 5 ml May be considered
3 2233 Carboplatin 150mg /15 ml Injection Vial May be considered
Firm Remarks: May be Considered
4 2234 Carboplatin 450mg / 45 ml Injection Vial May be considered
5 2269
Docetaxel 20mg/5ml or 20 mg/0.5 ml fill volume
in 5 ml vial May be considered
6 2270 Docetaxel 80mg/ 2 ml vial May be considered
7 2276
Each 20ml of reconstituted suspension contains:
Paclitaxel, USP-100mg Albumin Human USP-900
mg
The firm failed to produce product approval for
this product.
May not be
considered
Page 23 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
8 2300 Gemcitabine 200mg Injection vial May be considered
9 2372 Oxaliplatin 100mg Injection vial May be considered
10 2373 Oxaliplatin 50mg Injection vial May be considered
11 2374 Paclitaxel Injection 260mg vial May be considered
35Genetek Lifesciences
Pvt Ltd
1 655 Water for Injection IP 10 ml amp May be considered
Firm Remarks: May be considered after submission of Annexure VIII. All the required documents are not in order and not satisfactory.
Specified volume license for item code 2066 and 2388.
1 655 Water for Injection IP 10 ml amp May be considered
2 1462 Ethamsylate Injection125mg/ml 2 ml ampoule May be considered
3 2066 Atropine sulphate injection 0.6%, 10ml vials
May be considered after submission of specified
volume licenses for the item as per the tender
requirement
May not be
considered
4 2388
Potassium Chloride Injection 150mg/ml,10ml
Ampoule
May be considered after submission of specified
volume licenses for the item as per the tender
requirement
May not be
considered
36
GENNOVA
BIOPHARMACEUTICAL
S LIMITED
1 1966 Tissue plasminogen activator TPA 40mg May be considered
37Glenmark
Pharmaceuticals Ltd
Firm Remarks: May be Considered
Firm Remarks: May be Considered
1 1389 Clotrimazole Pessaries IP 100 mg May be considered
2 2289 Flucinolone Acetonide 0.1% w/w cream 30 gm May be considered
3 2290 Flucinolone Acetonide 0.01% w/w Lotion 30 ml May be considered
4 2316 Itraconazole Capsule 100 mg May be considered
5 2325 Levofloxacin Tablet 500 mg May be considered
Page 24 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 2334
Liquid Paraffin 3.75 ml + milk of Magnesia 11.25
ml each 15 ml contain 170 ml bottle Syrup May be considered
7 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
8 2418 Sertaconazole Nitrate (Pessaries) 500 mg Tablet May be considered
9 2419
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Bottle of 15 ml May be considered
10 2420
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Tube of 15 gms May be considered
38Grifols India Firm Remarks: May be considered after submission of valid manufacturing license (Certificate of manufacturing company of foreign
38Grifols India
Healthcare Pvt Ltd
1 1367 Human Albumin Solution I.P. 20% in100 ml bottle May be considered
2 2252
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried ) 250 IU May be considered
39 HEALERS LAB
1 37 Atenolol Tablets IP 50mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
2 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
3 279 Folic Acid Tablets 5mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
Firm Remarks: May be considered after submission of valid manufacturing license (Certificate of manufacturing company of foreign
company) and valid Annexure VIII.
Firm Remarks: May be considered after submission of latest product approvals for all products.
3 279 Folic Acid Tablets 5mg upto 24-03-2020. but not retained. considered
4 482 Norfloxacin Tablets IP 400mg May be considered
5 525 Paracetamol Tablets IP 500 mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
Page 25 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 1134 Risperidone Tablets USP 2 mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
7 1319 Pantaprazole (Enteric Coated) Tablets 40mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
8 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
May be considered if valid product approval is
9 1678 Methyl Cobalamin Tablets 500mcg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
10 1739 Atorvastatin Tablets IP 20mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
11 1794 Escitalopram Tablets 10mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
12 2065 Atorvastatin Tablets IP 10mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
May be considered if valid product approval is
13 2073 Citicoline Tab 500mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
14 2297 Gabapentin Tablets 300mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
15 2325 Levofloxacin Tablet 500 mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
consideredPage 26 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
16 2326 Levofloxacin Tablet 750 mg
May be considered if valid product approval is
produced. Firm submitted product approval valid
upto 24-03-2020. but not retained.
May not be
considered
40
HEALTHY LIFE
PHARMA PRIVATE
LIMITED
1 193 Dicyclomine Hcl Tablets 10 mg May be considered
2 201 Diethylcarbamazine Citrate Tablets IP 100mg May be considered
Firm Remarks: 1)May be considered after submission of Annexure II, Authorization letter nominating reponsible person with complete
details such as father name and intial with correct tender No. and Valid GMP certificate, Annexure VIII, XIII.
3 251 Enalapril Maleate Tablets IP 5mg May be considered
4 577 Prednesolone Tab 10mg Item is not in the product approval list
May not be
considered
5 1134 Risperidone Tablets USP 2 mg Item is not in the product approval list
May not be
considered
6 1254 Spironolactone Tablets IP 25 mg, May be considered
7 1389 Clotrimazole Pessaries IP 100 mg Item is not in the product approval list
May not be
considered
8 1438
Levothyroxine Tablets IP 100 micrograms(un
coated) Item is not in the product approval list
May not be
considered
9 1492 Prednesolone Tab 20mg Item is not in the product approval list
May not be
considered
10 1522 ACT Kit for Adults Item is not in the product approval list
May not be
considered
May not be
11 1523 ACT Kit for (9-14 years) Item Strength not mentioned
May not be
considered
12 1525 ACT Kit for (1-4 years) Item Strength not mentioned
May not be
considered
13 1526 ACT Kit for (0-1 years) Item is not in the product approval list
May not be
considered
14 1691 Aciclovir Tablets IP 400 mg May be considered
15 1975 Warfarin sodium Tablets IP 5 mg May be considered
Page 27 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
16 2111 Levothyroxine Tablets 50mcg May be considered
17 2125 Prazosin Tab 5mg May be considered
18 2313 Isosorbide Dinitrate Tablets 10mg Item is not in the product approval list
May not be
considered
19 2327 Levothyroxine Tablets 25mcg Item is not in the product approval list
May not be
considered
20 2343 Methyl Prednisolone IP 4mg Tablet Item is not in the product approval list
May not be
considered
21 2344 Methyl Prednisolone IP 8mg Tablet Item is not in the product approval list
May not be
considered21 2344 Methyl Prednisolone IP 8mg Tablet Item is not in the product approval list considered
22 2393 Pyridoxine HCL CR Tab. 100mg Item is not in the product approval list
May not be
considered
23 2429 Spironolactone Tablets IP 50 mg May be considered
41Hindustan
Laboratories
1 1370
Vitamin A Paediatric retinol solution 100000 IU
per ml May be considered
42INDIANA
OPHTALMICS
1 1377 Flurbiprofen Eye drops BP 0.03% 5 ml May be considered
2 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial May be considered
3 1905 Olopatadine eye drops 0.1%w/v May be considered
Firm Remarks: May be Considered
Firm Remarks: May be considered after submission of valid NCC certificate (not older than 6months).
3 1905 Olopatadine eye drops 0.1%w/v May be considered
4 1967 Tobramycin Eye drops 0.3% in 5 ml vial May be considered
5 2255 Cyclo Pentolate Eye drops 1% 5ml May be considered
6 2304
Hydroxy Propyl Methyl Cellulose Eye Drops 0.3%
in 10 ml May be considered
7 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial May be considered
Page 28 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
8 2423 Sodium Chloride Eye drops 5% 5ml May be considered
9 2434 Timolol Maleate eye Drops IP 0.5%, 5 ml May be considered
10 2475 Moxifloxacin + Prednisolone acetate Eye Drops May be considered
43 INDSWIFT LIMITED
1 40 Ascorbic Acid Tablets IP (Chewable) 500 mg May be considered
2 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
Firm Remarks: May be Considered
3 251 Enalapril Maleate Tablets IP 5mg May be considered
4 482 Norfloxacin Tablets IP 400mg May be considered
5 525 Paracetamol Tablets IP 500 mg May be considered
6 527.01 Paracetamol Injection 300mg in 2ml May be considered
7 564.01 Promethazine Hcl Syrup IP 5 mg / 5 ml in 60ml May be considered
8 577 Prednesolone Tab 10mg May be considered
9 1137 Domperidone Tablets IP 10 mg May be considered
10 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
11 1317 Ondansetron Tablets IP 4 mg May be considered
12 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
13 1370
Vitamin A Paediatric retinol solution 100000 IU
per ml May be considered
14 1492 Prednesolone Tab 20mg May be considered
15 1636 Isoxsuprine Hcl Tablets 10 mg May be considered
Page 29 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
16 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
17 1739 Atorvastatin Tablets IP 20mg May be considered
18 2065 Atorvastatin Tablets IP 10mg May be considered
19 2325 Levofloxacin Tablet 500 mg May be considered
44
INTAS
PHARMACEUTICALS
LTD.1 30 Acetazolamide Tablets IP 250 mg
Firm Remarks: May be considered after submission of valid GMP/WHO GMP certificate of license No M/717/2016
1 30 Acetazolamide Tablets IP 250 mg
2 1134 Risperidone Tablets USP 2 mg
May be considered after clarification of USP & IP
grade
May not be
considered
3 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
4 1739 Atorvastatin Tablets IP 20mg May be considered
5 1746 Bupropion Hcl Tablets 150 mg USP
May be considered after clarification of USP & IP
grade
May not be
considered
6 1820 Human Immunoglobulin IV 5 gm/100ml May be considered
7 1866 Mefloquine Hcl IP Tablets 250mg May be considered
8 1888 Mycophenolate mofetil Tab 500mg May be considered
9 1906 Oxybutynin Tablets BP 2.5mg
May be considered after clarification of USP & BP
grade
May not be
considered9 1906 Oxybutynin Tablets BP 2.5mg grade considered
10 1930 Ramipril Tablets IP 5mg
Item is not considered as the dosage form is
different
May not be
considered
11 1959 Tacrolimus Capsules 1mg May be considered
12 2073 Citicoline Tab 500mg May be considered
13 2205 Amitriptyline Tablets 25mg May be considered
Page 30 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
14 2252
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried ) 250 IU May be considered
15 2269
Docetaxel 20mg/5ml or 20 mg/0.5 ml fill volume
in 5 ml vial
Item is not considered as the volume approval as
per licence was 1ml & 4ml but required in 5ml
vial
May not be
considered
16 2270 Docetaxel 80mg/ 2 ml vial
Item is not considered as the product approval is
for export only
May not be
considered
17 2271 Donepezil Tablets 5mg May be considered
18 2292 Flunarizine Tablets 10mg May be considered
19 2293 Fluoxetine Capsule 20mg May be considered
20 2297 Gabapentin Tablets 300mg May be considered
21 2340 Memantine 10mg Tablet May be considered
22 2382 Phenytoin sodium Tablets IP 300mg May be considered
23 2397 Quetiapine 25mg Tablet May be considered
24 2398 Quetiapine 50mg Tablet May be considered
25 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
26 2483 CilnidipineTab 20mg May be considered
45 INTERMED Firm Remarks: May be considered after submission of latest renewal certificate for all approved products produced.45 INTERMED
1 37 Atenolol Tablets IP 50mg May be considered
2 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
3 211 Etophylline 77mg + Theophylline 23mg Tablets IP May be considered
4 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
5 482 Norfloxacin Tablets IP 400mg May be considered
Firm Remarks: May be considered after submission of latest renewal certificate for all approved products produced.
Page 31 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 577 Prednesolone Tab 10mg May be considered
7 1317 Ondansetron Tablets IP 4 mg May be considered
8 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
9 1389 Clotrimazole Pessaries IP 100 mg May be considered
10 1492 Prednesolone Tab 20mg May be considered
11 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered11 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
12 1650 Permethrin Cream 5% 30gms tube May be considered
13 1682 Salicylic Acid Cream 5% , 30gms tube May be considered
14 1691 Aciclovir Tablets IP 400 mg May be considered
15 1739 Atorvastatin Tablets IP 20mg May be considered
16 1888 Mycophenolate mofetil Tab 500mg May be considered
17 2065 Atorvastatin Tablets IP 10mg May be considered
18 2243 Clindamycin 1 % gel 30 gms May be considered
19 2297 Gabapentin Tablets 300mg May be considered
20 2325 Levofloxacin Tablet 500 mg May be considered
21 2326 Levofloxacin Tablet 750 mg May be considered
22 2366 Oint.Salicylic Acid IP 12.0% w/w 50 grms tube May be considered
23 2367 Oint.Salicylic Acid IP 6.0% w/w 30 grms tube May be considered
24 2429 Spironolactone Tablets IP 50 mg May be consideredPage 32 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
46JOHNSON AND SMITH
CO
1 40.02 Acetyl Salicylic Acid Tablets IP 150mg May be considered
2 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
3 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
4 265 Furosemide Tablets IP 40mg May be considered
5 279 Folic Acid Tablets 5mg May be considered
Firm Remarks: May be Considered
5 279 Folic Acid Tablets 5mg May be considered
6 285 Formaldehyde Solution 500ml bottle May be considered
7 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle May be considered
8 482 Norfloxacin Tablets IP 400mg May be considered
9 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts May be considered
10 525 Paracetamol Tablets IP 500 mg May be considered
11 577 Prednesolone Tab 10mg May be considered
12 605 Ranitidine Hcl (Film Coated) Tablets IP 150 mg May be considered
13 1137 Domperidone Tablets IP 10 mg May be considered13 1137 Domperidone Tablets IP 10 mg May be considered
14 1162 Loperamide Tablets 2mg May be considered
15 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
16 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
17 1470 Oseltamivir Cap 75mg May be considered
18 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be consideredPage 33 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
19 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
20 1665 Glycerin IP 450gm May be considered
21 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
22 1953 Sodium valporate Tablets IP 200mg May be considered
23 2062 Acetyl Salicylic acid Tablets IP 75mg May be considered
24 2065 Atorvastatin Tablets IP 10mg May be considered24 2065 Atorvastatin Tablets IP 10mg May be considered
25 2333 Liquid Paraffin 100 ml May be considered
26 2335 Liquid Paraffin 500ml May be considered
27 2366 Oint.Salicylic Acid IP 12.0% w/w 50 grms tube May be considered
28 2367 Oint.Salicylic Acid IP 6.0% w/w 30 grms tube May be considered
29 2375 Paraffin Wax 500 gms May be considered
47KONIS
PHARMACEUTICALS
1 107
Chloroquine Phosphate Injection IP 40 mg / ml in
3ml amp May be considered
2 266 Furosemide Injection , IP 10mg/1ml in 2 ml amp May be considered
Firm Remarks: May be considered after submission of latest NCC certificate (not older than 6months).
2 266 Furosemide Injection , IP 10mg/1ml in 2 ml amp May be considered
3 527.01 Paracetamol Injection 300mg in 2ml May be considered
4 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
5 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered
6 1700 Meropenam Injection IP 1gm vial May be considered
7 1752 Cefuroxime Injection IP 250 mg vial May be consideredPage 34 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
8 2319
Ketorolac Tromethamine Injection 30mg /ml, 1 ml
Ampoule May be considered
9 2330 Lignocaine Hydrochloride Injection I.P. 5% w/ v May be considered
10 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
48Lundbeck India
Private limited
1 2443
Zuclopenthixol (Acetate / Decanoate ) Injection I.P
50 mg May be considered
49M.J.BIOPHARM PVT.
LTD.,
Firm Remarks: May be considered after submission of valid NCC certificate (not older than 6months).
Firm Remarks: May be considered after submission of complete license.49LTD.,
1 1700 Meropenam Injection IP 1gm vial May be considered
50
MACLEODS
PHARMACEUTICALS
LTD
1 37 Atenolol Tablets IP 50mg May be considered
2 525 Paracetamol Tablets IP 500 mg May be considered
3 1145 Carbimazole Tablets 5mg May be considered
4 1317 Ondansetron Tablets IP 4 mg May be considered
5 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
Amoxycillin 500mg + 125mg Potassium Clavulanic
Firm Remarks: May be Considered
6 1340
Amoxycillin 500mg + 125mg Potassium Clavulanic
Acid Tablets IP May be considered
7 1438
Levothyroxine Tablets IP 100 micrograms(un
coated)
May be considered after submission of product
approval
May not be
considered
8 1621 Cefixime Dispersible Tablets USP 100 mg May be considered
9 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
10 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
Page 35 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
11 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered
12 1739 Atorvastatin Tablets IP 20mg May be considered
13 1752 Cefuroxime Injection IP 250 mg vial May be considered
14 1930 Ramipril Tablets IP 5mg May be considered
15 2065 Atorvastatin Tablets IP 10mg May be considered
16 2111 Levothyroxine Tablets 50mcg
May be considered after submission of product
approval
May not be
considered16 2111 Levothyroxine Tablets 50mcg approval considered
17 2113 Montelukast Tab 10mg May be considered
18 2146 Carbimazole Tablets 20mg May be considered
19 2231 Carbimazole Tablet 10mg May be considered
20 2316 Itraconazole Capsule 100 mg May be considered
21 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered
22 2325 Levofloxacin Tablet 500 mg May be considered
23 2326 Levofloxacin Tablet 750 mg May be considered
24 2327 Levothyroxine Tablets 25mcg
May be considered after submission of product
approval
May not be
considered
25 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
26 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
27 2428 Spiramycin Tablet 3.0 M.I.U May be considered
28 2483 CilnidipineTab 20mg May be considered
51MALIK LIFESCIENCES
PRIVATE LIMITEDFirm Remarks: May be Considered
Page 36 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
1 8
Amoxicillin oral suspension IP 125 mg / 5 ml in
60ml May be considered
2 1340
Amoxycillin 500mg + 125mg Potassium Clavulanic
Acid Tablets IP May be considered
3 1621 Cefixime Dispersible Tablets USP 100 mg May be considered
4 2235
Cefixime oral suspension 100mg / 5ml in 60ml
Bottle May be considered
52MARC LABORATORIES
LTD
1 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml
May be considered after submission of latest
renewal/retention certificate
May not be
considered
Firm Remarks: May be considered after submission of complete license and latest retention/renewals certificate & submitting
Manufacturing unit address, Shelf life in Annexure-VIII.
1 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml renewal/retention certificate considered
2 1621 Cefixime Dispersible Tablets USP 100 mg
May be considered after submission of latest
renewal/retention certificate
May not be
considered
3 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle
May be considered after submission of latest
renewal/retention certificate
May not be
considered
4 1700 Meropenam Injection IP 1gm vial
May be considered after submission of latest
renewal/retention certificate
May not be
considered
5 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
6 2235
Cefixime oral suspension 100mg / 5ml in 60ml
Bottle May be considered
53MARS THERAPEUTICS
and CHEMICALS LTD
1 40.02 Acetyl Salicylic Acid Tablets IP 150mg May be considered
Cotrimaxazole Tabs. IP 160mg+800mg
Firm Remarks: May be Considered
2 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
3 136 Carbmazepine Tablets (Film coated) 100mg May be considered
4 279 Folic Acid Tablets 5mg May be considered
5 525 Paracetamol Tablets IP 500 mg May be considered
6 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
Page 37 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
7 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
8 1953 Sodium valporate Tablets IP 200mg
May be considered after submission of approrval
for IP specification of the product
May not be
considered
9 2062 Acetyl Salicylic acid Tablets IP 75mg May be considered
10 2069 Carbmazepine Tablets 200mg May be considered
11 2287
Ferrous ascorbate equivalent to 50 mg Iron + Folic
acid 1.5 mg) tablet May be considered
12 2325 Levofloxacin Tablet 500 mg May be considered12 2325 Levofloxacin Tablet 500 mg May be considered
13 2326 Levofloxacin Tablet 750 mg May be considered
14 2440 Zinc Sulphate Dispersible Tablet10mg
May be considered after submission of approval
for Zinc Sulphate dispersable tablet.
May not be
considered
54MASCOT HEALTH
SERIES PVT LTD
1 8
Amoxicillin oral suspension IP 125 mg / 5 ml in
60ml May be considered
2 192 Doxycycline HCL Capsule IP 100 mg May be considered
3 1134 Risperidone Tablets USP 2 mg May be considered
4 1162 Loperamide Tablets 2mg May be considered
5 1317 Ondansetron Tablets IP 4 mg May be considered
Firm Remarks: May be Considered
5 1317 Ondansetron Tablets IP 4 mg May be considered
6 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
7 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
8 1389 Clotrimazole Pessaries IP 100 mg May be considered
9 1621 Cefixime Dispersible Tablets USP 100 mg
May be considered after submission of product
approval
May not be
considered
10 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream The License is given for only export
May not be
consideredPage 38 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
11 1691 Aciclovir Tablets IP 400 mg May be considered
12 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered
13 1794 Escitalopram Tablets 10mg May be considered
14 2065 Atorvastatin Tablets IP 10mg May be considered
15 2073 Citicoline Tab 500mg May be considered
16 2113 Montelukast Tab 10mg May be considered16 2113 Montelukast Tab 10mg May be considered
17 2126 Pregabalin SR Tablet 75mg
May be considered after submission of product
approval
May not be
considered
18 2127
Pregabalin SR 75mg + Methylcobalamin 1500mcg
Tablets May be considered
19 2205 Amitriptyline Tablets 25mg May be considered
20 2217 Betahistine Tablets IP 16 mg May be considered
21 2258 Deflozocort Tablets 6mg May be considered
22 2293 Fluoxetine Capsule 20mg May be considered
23 2325 Levofloxacin Tablet 500 mg May be considered
24 2326 Levofloxacin Tablet 750 mg May be considered
25 2382 Phenytoin sodium Tablets IP 300mg May be considered
26 2398 Quetiapine 50mg Tablet May be considered
27 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
55MED MANOR
ORGANICS PVT LTD
1 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
Firm Remarks: May be Considered
Page 39 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
2 1650 Permethrin Cream 5% 30gms tube
May be considered after clarification of cream or
Gel as per requirement
May not be
considered
3 1669 Betahistine Tablets IP 8 mg May be considered
4 2073 Citicoline Tab 500mg May be considered
5 2217 Betahistine Tablets IP 16 mg May be considered
6 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
7 2419
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Bottle of 15 ml May be considered7 2419 base q.s. Pack -Bottle of 15 ml May be considered
8 2420
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Tube of 15 gms
May be considered after clarification of the
medium i.ePropylene glycol Base
May not be
considered
56Meridian Enterprises
Pvt Ltd
1 1389 Clotrimazole Pessaries IP 100 mg May be considered
2 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml May be considered
3 2219 Bisacodyl Suppositories 10mg May be considered
4 2264 Diclofenac Sodium suppositories 100 mg May be considered
57MSD Pharmaceuticals
Private Limited
Quadrivalent Human Pappiloma Virus Vaccine
Firm Remarks: May be considered after submission of valid latest NCC Certificate (not older than 6months), Authorisation letter
issued by Mg.Director responsible as per Annexure XIV and shelf life and Batch size details of porducts.
Firm Remarks: May be considered after submission of NCC Certificate (not older than 6months) and Annexure VIII
1 2395
Quadrivalent Human Pappiloma Virus Vaccine
Injection (0.5ml PFS) May be considered
58
NECTAR
LABORATORIES
PRIVATE LIMITED
1 1700 Meropenam Injection IP 1gm vial May be considered
2 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
Firm Remarks: May be Considered
Page 40 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
59
NOVARTIS
HEALTHCARE PRIVATE
LIMITED
1 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial May be considered
60NOVO NORDISK INDIA
PVT LTD
1 2250
Coagulation Factor VIII rF VIII ( Recombinant or
Freeze Dried ) 1000 IU May be considered
2 2251
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried) 1500 IU May be considered
Coagulation Factor VIII rF VIII (Recombinant or
Firm Remarks: May be considered after submission of NCC Certificate (not older than 6months) and Annexure VIII
Firm Remarks: May be considered after submission of valid GMP/ WHO GMP Certificates.
3 2252
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried ) 250 IU May be considered
61
OTSUKA
PHARMACEUTICAL
INDIA PRIVATE
LIMITED
1 95
Ciprofloxacin Injection IP 200mg/100ml BFS /
FFS May be considered
2 224
Dextrose with Sodium Chloride Injection 5% +
0.9% IP in 500ml IV BFS / FFS May be considered
3 440 Metronidazole IV Infusion IP 500mg in 100 ml May be considered
4 655 Water for Injection IP 10 ml amp May be considered
5 1304 Lipids I.V. 20% In 250ml Bottles May be considered
Mannitol 20% I.V. Infusion IP 100ml bottle
Firm Remarks: May be Considered
6 1639
Mannitol 20% I.V. Infusion IP 100ml bottle
BFS/FFS May be considered
7 2262 Dextrose 10% I.V 500 ml May be considered
62
Paviour
Pharmaceuticals Pvt.
Ltd.
1 1367 Human Albumin Solution I.P. 20% in100 ml bottle May be considered
Firm Remarks: May be considered after submission of Annexure VIII with Manfacturing unit Address
Page 41 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
2 2309
IgM enriched Immunoglobulin IgM 12%, IgG 76%
& IgA 12% concentrate 10ml May be considered
3 2386 Porcine Lung Surfactant 1.5 ml 120mg May be considered
4 2387 Porcine Lung Surfactant 3ml 240mg May be considered
63 Pentagon Labs ltd
1 95
Ciprofloxacin Injection IP 200mg/100ml BFS /
FFS
May be considered after submission of latest
renewal/retention certificate of products.
May not be
considered
2 224
Dextrose with Sodium Chloride Injection 5% +
0.9% IP in 500ml IV BFS / FFS
May be considered after submission of latest
renewal/retention certificate of products.
May not be
considered
May be considered after submission of latest May not be
Firm Remarks: May be considered
3 440 Metronidazole IV Infusion IP 500mg in 100 ml
May be considered after submission of latest
renewal/retention certificate of products.
May not be
considered
4 1639
Mannitol 20% I.V. Infusion IP 100ml bottle
BFS/FFS
May be considered after submission of latest
renewal/retention certificate of products.
May not be
considered
5 2119
Paracetamol Solution for Infusion (10mg/ml) in
100ml glass bottle i.e.1gm/100ml BFS/FFS
May be considered after submission of latest
renewal/retention certificate of products.
May not be
considered
6 2262 Dextrose 10% I.V 500 ml
May be considered after submission of latest
renewal/retention certificate of products.
May not be
considered
64 Pfizer Limited
1 201 Diethylcarbamazine Citrate Tablets IP 100mg May be considered
2 279 Folic Acid Tablets 5mg May be considered
Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months) and Annexure-II authorized by
Mg.Director of the firm and nominating a responsible person authorized by Mg.Director of the firm and Annexure-XIII authorized by
Mg.Director of the firm and Annexure-VIII authorized by Mg.Director of the firm.
2 279 Folic Acid Tablets 5mg May be considered
3 577 Prednesolone Tab 10mg May be considered
4 1492 Prednesolone Tab 20mg May be considered
5 2125 Prazosin Tab 5mg May be considered
6 2337 Lorazepam Tablet 2mg May be considered
Page 42 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
65PFIZER PRODUCTS
INDIA PVT LTD
1 1310
Methyl Prednesolone Sodium Succinate Injection
USP 500 mg May be considered
2 2203 Adriamycin Injection 50mg / 25ml vial
May be considered after submission of product
approval
May not be
considered
3 2233 Carboplatin 150mg /15 ml Injection Vial May be considered
4 2234 Carboplatin 450mg / 45 ml Injection Vial May be considered
5 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
Firm Remarks: May be Considered
5 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
6 2250
Coagulation Factor VIII rF VIII ( Recombinant or
Freeze Dried ) 1000 IU May be considered
7 2252
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried ) 250 IU May be considered
8 2343 Methyl Prednisolone IP 4mg Tablet May be considered
9 2344 Methyl Prednisolone IP 8mg Tablet May be considered
66
Pharma Impex
Laboratories Private
Limited
1 95
Ciprofloxacin Injection IP 200mg/100ml BFS /
FFS May be considered
2 224
Dextrose with Sodium Chloride Injection 5% +
0.9% IP in 500ml IV BFS / FFS May be considered
Firm Remarks: May be considered after submission of corrected Annexure-VIII
3 440 Metronidazole IV Infusion IP 500mg in 100 ml May be considered
4 1639
Mannitol 20% I.V. Infusion IP 100ml bottle
BFS/FFS May be considered
5 1700 Meropenam Injection IP 1gm vial May be considered
6 1752 Cefuroxime Injection IP 250 mg vial May be considered
Page 43 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
7 2119
Paracetamol Solution for Infusion (10mg/ml) in
100ml glass bottle i.e.1gm/100ml BFS/FFS May be considered
8 2262 Dextrose 10% I.V 500 ml May be considered
67
Premium Serums and
Vaccines Privated
Limited
1 632 Antisnake Venom Injection May be considered
68 PROTECH TELELINKS
Dopamine Hcl Injection IP 200mg in 5ml vial and May not be
Firm Remarks: May be Considered
Firm Remarks: May be Considered
1 209
Dopamine Hcl Injection IP 200mg in 5ml vial and
ampoule in composition each ml contains Dobutamive Hcl
May not be
considered
2 1218
Dobutamine Hcl For Injection USP 250mg / 20 ml
Vial May be considered
3 1310
Methyl Prednesolone Sodium Succinate Injection
USP 500 mg May be considered
4 1377 Flurbiprofen Eye drops BP 0.03% 5 ml May be considered
5 1455 Betaxolol eye Drops 0.25%, 5 ml May be considered
6 1479 Acyclovir Injection 250mg May be considered
7 1683
Triamcinalone acetate Injection IP 40mg/ml 1ml
vial May be considered
8 1694 Labetalol Hcl Injection IP 5mg / ml in 10ml vial May be considered
9 1700 Meropenam Injection IP 1gm vial May be considered
10 1752 Cefuroxime Injection IP 250 mg vial May be considered
11 1905 Olopatadine eye drops 0.1%w/v May be considered
12 1967 Tobramycin Eye drops 0.3% in 5 ml vial May be considered
13 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
Page 44 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
14 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
15 2425 Sodium Valporate Injection 500mg / 5ml Vial May be considered
16 2432 Thiamine Injection 100mg / ml vial 2 ml May be considered
17 2434 Timolol Maleate eye Drops IP 0.5%, 5 ml May be considered
69
PULSE
PHARMACEUTICALS
PRIVATE LIMITEDClopidogrel Bisulphate Tablets I.P. 75mg,(Film
Firm Remarks: May be Considered
1 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
2 1678 Methyl Cobalamin Tablets 500mcg May be considered
3 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
4 1794 Escitalopram Tablets 10mg May be considered
5 2073 Citicoline Tab 500mg May be considered
6 2217 Betahistine Tablets IP 16 mg May be considered
7 2281 Escitalopram Tablets 5mg May be considered
8 2297 Gabapentin Tablets 300mg May be considered
9 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
70
PURE AND CURE
HEALTHCARE PRIVATE
LIMITED
1 37 Atenolol Tablets IP 50mg May be considered
2 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
Firm Remarks: May be Considered
Page 45 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
3 251 Enalapril Maleate Tablets IP 5mg May be considered
4 279 Folic Acid Tablets 5mg May be considered
5 525 Paracetamol Tablets IP 500 mg May be considered
6 1134 Risperidone Tablets USP 2 mg May be considered
7 1137 Domperidone Tablets IP 10 mg May be considered
8 1317 Ondansetron Tablets IP 4 mg May be considered8 1317 Ondansetron Tablets IP 4 mg May be considered
9 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
10 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
11 1470 Oseltamivir Cap 75mg May be considered
12 1705 Alprazolam Tablets IP 0.5 mg May be considered
13 1739 Atorvastatin Tablets IP 20mg May be considered
14 1794 Escitalopram Tablets 10mg May be considered
15 1903 Olanzapine Tablets 5 mg May be considered
16 1953 Sodium valporate Tablets IP 200mg May be considered
17 2065 Atorvastatin Tablets IP 10mg May be considered
18 2080 Diclofenac Sodium Tablets 100mg SR May be considered
19 2126 Pregabalin SR Tablet 75mg May be considered
20 2127
Pregabalin SR 75mg + Methylcobalamin 1500mcg
Tablets May be considered
21 2140 Sodium Valporate Tab 500mg May be consideredPage 46 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
22 2205 Amitriptyline Tablets 25mg May be considered
23 2281 Escitalopram Tablets 5mg May be considered
24 2292 Flunarizine Tablets 10mg May be considered
25 2293 Fluoxetine Capsule 20mg May be considered
26 2297 Gabapentin Tablets 300mg May be considered
27 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered27 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered
71
Rathnam
pharmaceuticals pvt
ltd
1 40 Ascorbic Acid Tablets IP (Chewable) 500 mg May be considered
2 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg
May be considered after submission of latest
product approval list.
May not be
considered
3 207 Diltiazem Tablets IP 30 mg
May be considered after submission of latest
product approval list.
May not be
considered
4 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts
May be considered after submission of latest
product approval list.
May not be
considered
5 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated)
May be considered after submission of latest
product approval list.
May not be
considered
6 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml
May be considered after submission of latest
product approval list.
May not be
considered
May be considered after submission of latest May not be
Firm Remarks: May be considered after submission of valid NCC certificate (not older than 6months) and Authorization letter of
nominating responsible person and valid GMP/WHO-GMP Certificate and All Products approval licenses.
7 2126 Pregabalin SR Tablet 75mg
May be considered after submission of latest
product approval list.
May not be
considered
8 2325 Levofloxacin Tablet 500 mg
May be considered after submission of latest
product approval list.
May not be
considered
72Reliance life sciences
pvt ltd
1 1367 Human Albumin Solution I.P. 20% in100 ml bottle May be considered
2 1820 Human Immunoglobulin IV 5 gm/100ml May be considered
Firm Remarks: May be Considered
Page 47 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
3 1966 Tissue plasminogen activator TPA 40mg May be considered
4 2252
Coagulation Factor VIII rF VIII (Recombinant or
Freeze Dried ) 250 IU May be considered
73REVAT LABORATORIES
PRIVATE LIMITED
1 37 Atenolol Tablets IP 50mg May be considered
2 40 Ascorbic Acid Tablets IP (Chewable) 500 mg May be considered
Cotrimaxazole Tabs. IP 160mg+800mg
Firm Remarks: May be Considered
3 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
4 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg May be considered
5 106
Chloroquine Phosphate Tablets IP 250 mg
base(Equivalent to 155 mg of Chloroquine ) May be considered
6 192 Doxycycline HCL Capsule IP 100 mg May be considered
7 211 Etophylline 77mg + Theophylline 23mg Tablets IP May be considered
8 482 Norfloxacin Tablets IP 400mg May be considered
9 525 Paracetamol Tablets IP 500 mg May be considered
10 743 Furazolidone Suspension IP 25mg/5ml,60ml May be considered
Domperidone Suspension IP 1 mg / ml in 30ml
11 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
12 1370
Vitamin A Paediatric retinol solution 100000 IU
per ml May be considered
13 1621 Cefixime Dispersible Tablets USP 100 mg May be considered
14 1626
Chlorpheniramine Maleate Syrup 2 mg / 5ml in
60ml bottle May be considered
15 1629 Fluconazole Tablets IP 200mg May be considered
Page 48 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
16 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle May be considered
17 1643
Metronidazole benzoate Oral Suspention IP
100mg/5ml in 60ml May be considered
18 1699 Azithromycin Dispersible Tablet 100 Mg May be considered
19 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
20 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered
21 1713 IFA syrup May be considered21 1713 IFA syrup May be considered
22 1739 Atorvastatin Tablets IP 20mg May be considered
23 2065 Atorvastatin Tablets IP 10mg May be considered
24 2069 Carbmazepine Tablets 200mg May be considered
25 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle May be considered
26 2325 Levofloxacin Tablet 500 mg May be considered
74RIDLEY LIFE SCIENCE
PRIVATE LIMITED
1 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg May be considered
2 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle May be considered
Firm Remarks: May be considered after submission of valid NCC certificate of NW(0109)/MNB/17 and NW(110)/MNB/17 (Not older
than 6months) and submitted Annexure-VIII but not given the shelf life for applied products.
2 311 bottle May be considered
3 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
4 743 Furazolidone Suspension IP 25mg/5ml,60ml May be considered
5 753 Povidone Iodine Solution 5% , 500ml bottle May be considered
6 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
7 1389 Clotrimazole Pessaries IP 100 mg May be consideredPage 49 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
8 1625
Chloroquine Phosphate Syrup 50 mg / 5 ml in
60ml May be considered
9 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
10 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle
May be considered after submission of latest
product approval
May not be
considered
11 1643
Metronidazole benzoate Oral Suspention IP
100mg/5ml in 60ml May be considered
12 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
13 1650 Permethrin Cream 5% 30gms tube May be considered13 1650 Permethrin Cream 5% 30gms tube May be considered
14 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
15 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
16 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered
17 1713 IFA syrup May be considered
18 2235
Cefixime oral suspension 100mg / 5ml in 60ml
Bottle May be considered
19 2236 Cefixime Oral Suspension 25mg/ml, 10ml Bottle May be considered
20 2243 Clindamycin 1 % gel 30 gms May be considered
21 2289 Flucinolone Acetonide 0.1% w/w cream 30 gm May be considered
22 2290 Flucinolone Acetonide 0.01% w/w Lotion 30 ml May be considered
23 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle May be considered
24 2366 Oint.Salicylic Acid IP 12.0% w/w 50 grms tube May be considered
25 2367 Oint.Salicylic Acid IP 6.0% w/w 30 grms tube May be considered
26 2419
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Bottle of 15 ml May be consideredPage 50 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
27 2420
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Tube of 15 gms May be considered
75RUSAN PHARMA
LIMITED
1 1804 Fentanyl Inj. 100mcg/2ml May be considered
2 1890 Naloxone HCL Injection USP 400mcg/ml, 1ml amp May be considered
3 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules item composition not tallied
May not be
considered
76 Sai Parenterals Pvt.Ltd
Firm Remarks: May be considered after submission of Autorization letter nominating a responsible person (Authoriazation given by
another authorized signatury, Who's authorization name not submitted.)
Firm Remarks: May be Considered76 Sai Parenterals Pvt.Ltd
1 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
2 1310
Methyl Prednesolone Sodium Succinate Injection
USP 500 mg May be considered
3 1700 Meropenam Injection IP 1gm vial May be considered
4 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
5 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
6 2432 Thiamine Injection 100mg / ml vial 2 ml May be considered
77
SALAS
PHARMACEUTICALS
PVT LTDMay be considered after submission of latest May not be
Firm Remarks: May be Considered
1 1134 Risperidone Tablets USP 2 mg
May be considered after submission of latest
product approval
May not be
considered
2 1317 Ondansetron Tablets IP 4 mg May be considered
3 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
4 1739 Atorvastatin Tablets IP 20mg May be considered
5 1794 Escitalopram Tablets 10mg May be considered
Page 51 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 1808 Flunarazine Tablets 5mg May be considered
7 1903 Olanzapine Tablets 5 mg
May be considered after submission of latest
product approval
May not be
considered
8 1930 Ramipril Tablets IP 5mg May be considered
9 2065 Atorvastatin Tablets IP 10mg May be considered
10 2126 Pregabalin SR Tablet 75mg May be considered
11 2127
Pregabalin SR 75mg + Methylcobalamin 1500mcg
Tablets May be considered11 2127 Tablets May be considered
12 2205 Amitriptyline Tablets 25mg May be considered
13 2217 Betahistine Tablets IP 16 mg
May be considered after submission of latest
product approval
May not be
considered
14 2258 Deflozocort Tablets 6mg May be considered
15 2271 Donepezil Tablets 5mg May be considered
16 2281 Escitalopram Tablets 5mg May be considered
17 2292 Flunarizine Tablets 10mg May be considered
18 2297 Gabapentin Tablets 300mg
May be considered after submission of latest
product approval
May not be
considered
19 2368 Olanzapine Tablets 2.5mg
May be considered after submission of latest
product approval
May not be
considered
20 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
78 SAMKEM
1 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts May be considered
2 564.01 Promethazine Hcl Syrup IP 5 mg / 5 ml in 60ml May be considered
3 743 Furazolidone Suspension IP 25mg/5ml,60ml May be considered
Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months)
Page 52 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
4 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
5 1625
Chloroquine Phosphate Syrup 50 mg / 5 ml in
60ml May be considered
6 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle
May be considered after submission of approval
for the strength 3.325gm/5ml
May not be
considered
7 1665 Glycerin IP 450gm
May be considered after submission of product
approval
May not be
considered
8 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
9 2333 Liquid Paraffin 100 ml
May be considered after submission of product
approval
May not be
considered9 2333 Liquid Paraffin 100 ml approval considered
10 2335 Liquid Paraffin 500ml
May be considered after submission of product
approval
May not be
considered
11 2375 Paraffin Wax 500 gms
May be considered after submission of product
approval
May not be
considered
79Sandoz Private
Limited
1 2310
Indacaterol 110mcg+Glycopyrronium 50 mcg
Capsules+ inhaler May be considered
2 2416 Sacubutril + Valsartan film coated Tablet 50mg May be considered
80 Sanofi India Limited
1 2295 Framycetin Sulphate Cream 1% w/w 100gm tube May be considered
2 2296 Framycetin Sulphate Cream 1% w/w 30gm tube May be considered
Firm Remarks: May be Considered
Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months)
81 SEEKO BIOTICS
1 37 Atenolol Tablets IP 50mg May be considered
2 40 Ascorbic Acid Tablets IP (Chewable) 500 mg
May be considered after submission of latest
product approval
May not be
considered
3 136 Carbmazepine Tablets (Film coated) 100mg
May be considered after submission of latest
product approval
May not be
considered
Firm Remarks: All the Required documents are not in order and not satisfactory but firm may be considered after giving
proper/satisfactory explanation on arrangement of documents. Also not enclosed Annexure-II & Non-conviction certificate (not older
than 6months)
Page 53 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
4 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
5 207 Diltiazem Tablets IP 30 mg May be considered
6 251 Enalapril Maleate Tablets IP 5mg May be considered
7 265 Furosemide Tablets IP 40mg May be considered
8 279 Folic Acid Tablets 5mg May be considered
9 482 Norfloxacin Tablets IP 400mg May be considered9 482 Norfloxacin Tablets IP 400mg May be considered
10 577 Prednesolone Tab 10mg May be considered
11 1137 Domperidone Tablets IP 10 mg May be considered
12 1145 Carbimazole Tablets 5mg May be considered
13 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
14 1492 Prednesolone Tab 20mg May be considered
15 1521 Primaquine Tablets IP 2.5 mg May be considered
16 1621 Cefixime Dispersible Tablets USP 100 mg May be considered
17 1691 Aciclovir Tablets IP 400 mg May be considered
18 1739 Atorvastatin Tablets IP 20mg May be considered
19 1794 Escitalopram Tablets 10mg May be considered
20 1808 Flunarazine Tablets 5mg
May be considered after submission of latest
product approval
May not be
considered
21 1903 Olanzapine Tablets 5 mg May be considered
22 1930 Ramipril Tablets IP 5mg May be consideredPage 54 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
23 1953 Sodium valporate Tablets IP 200mg May be considered
24 2065 Atorvastatin Tablets IP 10mg May be considered
25 2113 Montelukast Tab 10mg May be considered
26 2126 Pregabalin SR Tablet 75mg May be considered
27 2127
Pregabalin SR 75mg + Methylcobalamin 1500mcg
Tablets May be considered
28 2146 Carbimazole Tablets 20mg May be considered28 2146 Carbimazole Tablets 20mg May be considered
29 2205 Amitriptyline Tablets 25mg May be considered
30 2258 Deflozocort Tablets 6mg May be considered
31 2281 Escitalopram Tablets 5mg May be considered
32 2292 Flunarizine Tablets 10mg
May be considered after submission of latest
product approval
May not be
considered
33 2313 Isosorbide Dinitrate Tablets 10mg May be considered
34 2325 Levofloxacin Tablet 500 mg May be considered
35 2343 Methyl Prednisolone IP 4mg Tablet May be considered
36 2397 Quetiapine 25mg Tablet May be considered
37 2398 Quetiapine 50mg Tablet May be considered
38 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
82
SHINE
PHARMACEUTICALS
LTD
1 1134 Risperidone Tablets USP 2 mg May be considered
Firm Remarks: May be Considered
Page 55 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
2 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
3 1678 Methyl Cobalamin Tablets 500mcg May be considered
4 1705 Alprazolam Tablets IP 0.5 mg May be considered
5 1739 Atorvastatin Tablets IP 20mg May be considered
6 1794 Escitalopram Tablets 10mg May be considered
7 1953 Sodium valporate Tablets IP 200mg May be considered7 1953 Sodium valporate Tablets IP 200mg May be considered
8 2065 Atorvastatin Tablets IP 10mg May be considered
9 2205 Amitriptyline Tablets 25mg May be considered
10 2297 Gabapentin Tablets 300mg May be considered
83Shree Anand Life
Sciences Ltd
1 209
Dopamine Hcl Injection IP 200mg in 5ml vial and
ampoule May be considered
2 266 Furosemide Injection , IP 10mg/1ml in 2 ml amp May be considered
3 655 Water for Injection IP 10 ml amp May be considered
4 1188 Amikacin Sulphate Injection IP 100 mg / 2 ml May be considered
5 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered
6 1218
Dobutamine Hcl For Injection USP 250mg / 20 ml
Vial May be considered
Firm Remarks: May be Considered
6 1218 Vial May be considered7 1479 Acyclovir Injection 250mg May be considered
8 1694 Labetalol Hcl Injection IP 5mg / ml in 10ml vial May be considered
9 2066 Atropine sulphate injection 0.6%, 10ml vials May be considered
10 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
11 2319
Ketorolac Tromethamine Injection 30mg /ml, 1 ml
Ampoule May be considered12 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules May be considered
13 2388
Potassium Chloride Injection 150mg/ml,10ml
Ampoule May be consideredPage 56 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
14 2411 Ropivacaine Injection 0.75mg%, 10ml Vial May be considered
84
SM
PHARMACEUTICALS
PVT LTD
1 285 Formaldehyde Solution 500ml bottle
May be considered after submission of latest
product approval
May not be
considered
2 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle
May be considered after submission of latest
product approval
May not be
considered
3 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts May be considered
Firm Remarks: May be Considered
4 743 Furazolidone Suspension IP 25mg/5ml,60ml May be considered
5 753 Povidone Iodine Solution 5% , 500ml bottle May be considered
6 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
7 1177 Hydrogen Peroxide Solution IP 6% in 200ml May be considered
8 1370
Vitamin A Paediatric retinol solution 100000 IU
per ml
May be considered after submission of latest
product approval
May not be
considered
9 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
10 1665 Glycerin IP 450gm
May be considered after submission of latest
product approval
May not be
considered
11 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml
May be considered after clarification of Adult/
paediatric as the product approval is submitted
for paediatric
May not be
considered11 1701 / 5 ml in 60ml for paediatric considered
12 1713 IFA syrup
May be considered after submission of latest
product approval
May not be
considered
13 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle May be considered
14 2333 Liquid Paraffin 100 ml
May be considered after submission of latest
product approval
May not be
considered
15 2335 Liquid Paraffin 500ml
May be considered after submission of latest
product approval
May not be
considered
Page 57 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
16 2375 Paraffin Wax 500 gms
May be considered after submission of latest
product approval
May not be
considered
85
STALLION
LABORATORIES PVT
LTD
1 192 Doxycycline HCL Capsule IP 100 mg May be considered
2 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
3 251 Enalapril Maleate Tablets IP 5mg May be considered
May be considered after submission of product May not be
Firm Remarks: May be considered after submission of valid NCC Certificate (not older than 6months) and Annexure VIII (Shelf life not
produced).
4 482 Norfloxacin Tablets IP 400mg
May be considered after submission of product
approval
May not be
considered
5 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts
May be considered after submission of product
approval
May not be
considered
6 1137 Domperidone Tablets IP 10 mg May be considered
7 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
8 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
9 1739 Atorvastatin Tablets IP 20mg May be considered
10 1903 Olanzapine Tablets 5 mg
May be considered after submission of product
approval
May not be
considered
11 2065 Atorvastatin Tablets IP 10mg May be considered
12 2069 Carbmazepine Tablets 200mg May be considered
13 2080 Diclofenac Sodium Tablets 100mg SR May be considered
14 2205 Amitriptyline Tablets 25mg May be considered
15 2297 Gabapentin Tablets 300mg
May be considered after submission of product
approval
May not be
considered
16 2313 Isosorbide Dinitrate Tablets 10mg
May be considered after submission of product
approval
May not be
considered
Page 58 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
17 2316 Itraconazole Capsule 100 mg
May be considered after submission of product
approval
May not be
considered
18 2325 Levofloxacin Tablet 500 mg
May be considered after submission of product
approval
May not be
considered
19 2326 Levofloxacin Tablet 750 mg
May be considered after submission of product
approval
May not be
considered
86STRIDE ORGANICS
PVT LTD
1 37 Atenolol Tablets IP 50mg May be considered
2 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
Firm Remarks: May be Considered
2 97 (Trimethoprim+Sulphamethoxazole ) May be considered
3 106
Chloroquine Phosphate Tablets IP 250 mg
base(Equivalent to 155 mg of Chloroquine ) May be considered
4 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
5 201 Diethylcarbamazine Citrate Tablets IP 100mg May be considered
6 279 Folic Acid Tablets 5mg May be considered
7 482 Norfloxacin Tablets IP 400mg May be considered
8 525 Paracetamol Tablets IP 500 mg May be considered
9 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
10 1340
Amoxycillin 500mg + 125mg Potassium Clavulanic
Acid Tablets IP May be considered10 1340 Acid Tablets IP May be considered
11 1621 Cefixime Dispersible Tablets USP 100 mg May be considered
12 1626
Chlorpheniramine Maleate Syrup 2 mg / 5ml in
60ml bottle May be considered
13 1678 Methyl Cobalamin Tablets 500mcg May be considered
14 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
15 1713 IFA syrup May be considered
Page 59 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
16 1739 Atorvastatin Tablets IP 20mg May be considered
17 2065 Atorvastatin Tablets IP 10mg May be considered
18 2080 Diclofenac Sodium Tablets 100mg SR May be considered
19 2225
Calcium Citrate 1000 mg+ Vit. D3 200 I.U.
Methylcobalamin 500 mcg+ Folic Acid 5mg +
Pyridoxine Hcl 10 mg May be considered
20 2287
Ferrous ascorbate equivalent to 50 mg Iron + Folic
acid 1.5 mg) tablet May be considered
SUDARSHAN
87
SUDARSHAN
PHARMACEUTICALS
PVT LTD
1 37 Atenolol Tablets IP 50mg May be considered
2 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
3 482 Norfloxacin Tablets IP 400mg May be considered
4 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts May be considered
5 525 Paracetamol Tablets IP 500 mg May be considered
88Super Formulations
Pvt. Ltd.
1 192 Doxycycline HCL Capsule IP 100 mg May be considered
Firm Remarks: May be Considered
Firm Remarks: May be Considered
1 192 Doxycycline HCL Capsule IP 100 mg May be considered
2 279 Folic Acid Tablets 5mg May be considered
3 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
4 482 Norfloxacin Tablets IP 400mg May be considered
5 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts May be considered
Page 60 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 525 Paracetamol Tablets IP 500 mg May be considered
7 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
8 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
9 1650 Permethrin Cream 5% 30gms tube May be considered
10 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
11 2243 Clindamycin 1 % gel 30 gms May be considered11 2243 Clindamycin 1 % gel 30 gms May be considered
12 2293 Fluoxetine Capsule 20mg May be considered
13 2325 Levofloxacin Tablet 500 mg May be considered
14 2420
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Tube of 15 gms May be considered
89SWISS PARENTERALS
PVT. LTD.
1 209
Dopamine Hcl Injection IP 200mg in 5ml vial and
ampoule May be considered
2 664 Thiopentone Sodium Injection IP 0.5gm /ml May be considered
3 1310
Methyl Prednesolone Sodium Succinate Injection
USP 500 mg May be considered
Firm Remarks: May be Considered
4 1462 Ethamsylate Injection125mg/ml 2 ml ampoule May be considered
5 1479 Acyclovir Injection 250mg May be considered
6 1683
Triamcinalone acetate Injection IP 40mg/ml 1ml
vial May be considered
7 1700 Meropenam Injection IP 1gm vial May be considered
8 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
Page 61 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
9 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules May be considered
10 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
11 2434 Timolol Maleate eye Drops IP 0.5%, 5 ml May be considered
90 Syndicate Pharma
1 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg May be considered
2 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
Oral Rehydration Salts IP (ORS) 20.5gm WHO
Firm Remarks: May be Considered
3 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts May be considered
4 743 Furazolidone Suspension IP 25mg/5ml,60ml May be considered
5 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
6 1625
Chloroquine Phosphate Syrup 50 mg / 5 ml in
60ml May be considered
7 1626
Chlorpheniramine Maleate Syrup 2 mg / 5ml in
60ml bottle May be considered
8 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
9 1643
Metronidazole benzoate Oral Suspention IP
100mg/5ml in 60ml May be considered
10 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
11 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
12 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
13 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered
14 2280
Erythromycin Syp 60 ml ( each 5ml contains 125
mg) May be considered
15 2323 Levocetrizine Syrup 2.5mg/5ml in 60ml bottle May be considered
Page 62 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
16 2420
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Tube of 15 gms May be considered
91
Synokem
Pharmaceuticals
Limited
1 279 Folic Acid Tablets 5mg May be considered
2 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle May be considered
3 1678 Methyl Cobalamin Tablets 500mcg May be considered
Firm Remarks: May be Considered
4 1699 Azithromycin Dispersible Tablet 100 Mg May be considered
5 1739 Atorvastatin Tablets IP 20mg May be considered
6 2065 Atorvastatin Tablets IP 10mg May be considered
7 2325 Levofloxacin Tablet 500 mg
May be considered after submission of latest valid
product license
May not be
considered
92SYSTOCHEM
LABORATORIES LTD
1 209
Dopamine Hcl Injection IP 200mg in 5ml vial and
ampoule May be considered
2 266 Furosemide Injection , IP 10mg/1ml in 2 ml amp May be considered
3 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
Firm Remarks: May be Considered
4 527.01 Paracetamol Injection 300mg in 2ml May be considered
5 714
Menadione Sodium Bisulphate Inj 10mg/ml 1ml
Amp USP May be considered
6 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered
7 1218
Dobutamine Hcl For Injection USP 250mg / 20 ml
Vial May be considered
8 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml May be considered
Page 63 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
9 1462 Ethamsylate Injection125mg/ml 2 ml ampoule May be considered
10 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
11 1650 Permethrin Cream 5% 30gms tube May be considered
12 1682 Salicylic Acid Cream 5% , 30gms tube May be considered
13 1683
Triamcinalone acetate Injection IP 40mg/ml 1ml
vial May be considered
14 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered14 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered
15 2066 Atropine sulphate injection 0.6%, 10ml vials
May be considered after clarification of regarding
pack size
May not be
considered
16 2243 Clindamycin 1 % gel 30 gms May be considered
17 2244
Clindamycin 1% w/w + Benzoyl Peroxide 2.5 w/w
15 gms May be considered
18 2245 Clindamycin Injection 150 mg/ml in 2ml ampoule May be considered
19 2289 Flucinolone Acetonide 0.1% w/w cream 30 gm May be considered
20 2304
Hydroxy Propyl Methyl Cellulose Eye Drops 0.3%
in 10 ml May be considered
21 2319
Ketorolac Tromethamine Injection 30mg /ml, 1 ml
Ampoule May be considered
22 2366 Oint.Salicylic Acid IP 12.0% w/w 50 grms tube May be considered
23 2367 Oint.Salicylic Acid IP 6.0% w/w 30 grms tube May be considered
24 2383 Piperacillin + tazobactum Injection 2gm +0.25gm May be considered
25 2432 Thiamine Injection 100mg / ml vial 2 ml
May be considered after submission of latest
valid product license with required strength
May not be
considered
93 TABLETS INDIA LTD
1 2119
Paracetamol Solution for Infusion (10mg/ml) in
100ml glass bottle i.e.1gm/100ml BFS/FFS May be considered
Firm Remarks: May be Considered
Page 64 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
2 2385
Polyethylene glycon with elecrolytes for oral
solution 137.15 gms powder May be considered
94
THE
SWASTIKPHARMACEU
TICALS
1 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle May be considered
2 753 Povidone Iodine Solution 5% , 500ml bottle May be considered
3 1665 Glycerin IP 450gm May be considered
Paracetamol Syrup IP (Non Alcohol based) 125 mg
Firm Remarks: May be considered after submission of valid GMP / WHO GMP Certificate.
4 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
5 2333 Liquid Paraffin 100 ml May be considered
6 2335 Liquid Paraffin 500ml May be considered
95TRIVENI
FORMULATIONS LTD
1 192 Doxycycline HCL Capsule IP 100 mg May be considered
2 279 Folic Acid Tablets 5mg May be considered
3 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
4 1678 Methyl Cobalamin Tablets 500mcg May be considered
Firm Remarks: May be Considered
4 1678 Methyl Cobalamin Tablets 500mcg May be considered
5 1739 Atorvastatin Tablets IP 20mg May be considered
6 1794 Escitalopram Tablets 10mg May be considered
7 2065 Atorvastatin Tablets IP 10mg May be considered
8 2073 Citicoline Tab 500mg May be considered
Page 65 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
9 2080 Diclofenac Sodium Tablets 100mg SR May be considered
10 2217 Betahistine Tablets IP 16 mg May be considered
11 2297 Gabapentin Tablets 300mg May be considered
12 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered
13 2398 Quetiapine 50mg Tablet May be considered
96 Unicure India Pvt. Ltd. Firm Remarks: May be Considered
1 30 Acetazolamide Tablets IP 250 mg May be considered
2 37 Atenolol Tablets IP 50mg May be considered
3 40 Ascorbic Acid Tablets IP (Chewable) 500 mg May be considered
4 40.02 Acetyl Salicylic Acid Tablets IP 150mg May be considered
5 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
6 98 Cotrimaxazole Oral Suspension IP. 40mg+200mg May be considered
7 106
Chloroquine Phosphate Tablets IP 250 mg
base(Equivalent to 155 mg of Chloroquine )
May be considered after submission of latest valid
product license
May not be
considered
8 192 Doxycycline HCL Capsule IP 100 mg May be considered8 192 Doxycycline HCL Capsule IP 100 mg May be considered
9 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
10 201 Diethylcarbamazine Citrate Tablets IP 100mg May be considered
11 207 Diltiazem Tablets IP 30 mg May be considered
12 211 Etophylline 77mg + Theophylline 23mg Tablets IP May be considered
13 251 Enalapril Maleate Tablets IP 5mg May be consideredPage 66 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
14 265 Furosemide Tablets IP 40mg May be considered
15 279 Folic Acid Tablets 5mg May be considered
16 308 Griseofulvin Tablets IP 125 mg May be considered
17 311
Gamma Benzene Hexachloride Lotion 1% in 60ml
bottle May be considered
18 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
19 482 Norfloxacin Tablets IP 400mg May be considered19 482 Norfloxacin Tablets IP 400mg May be considered
20 513.01
Oral Rehydration Salts IP (ORS) 20.5gm WHO
formula with citrate salts May be considered
21 525 Paracetamol Tablets IP 500 mg May be considered
22 564.01 Promethazine Hcl Syrup IP 5 mg / 5 ml in 60ml May be considered
23 577 Prednesolone Tab 10mg May be considered
24 605 Ranitidine Hcl (Film Coated) Tablets IP 150 mg May be considered
25 743 Furazolidone Suspension IP 25mg/5ml,60ml May be considered
26 753 Povidone Iodine Solution 5% , 500ml bottle May be considered
27 1134 Risperidone Tablets USP 2 mg May be considered
28 1137 Domperidone Tablets IP 10 mg May be considered
29 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May be considered
30 1162 Loperamide Tablets 2mg May be considered
31 1254 Spironolactone Tablets IP 25 mg, May be considered
32 1257 Tamoxifen Citrate Tablets IP 10 mg, May be consideredPage 67 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
33 1317 Ondansetron Tablets IP 4 mg May be considered
34 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
35 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
36 1370
Vitamin A Paediatric retinol solution 100000 IU
per ml May be considered
37 1389 Clotrimazole Pessaries IP 100 mg May be considered
38 1438
Levothyroxine Tablets IP 100 micrograms(un
coated) May be considered38 1438 coated) May be considered
39 1470 Oseltamivir Cap 75mg May be considered
40 1474
Sulfadoxine + Pyrimethamine 500 mg Sulfadoxine
+ 25 mg Pyrimethamine Tablets IP May be considered
41 1492 Prednesolone Tab 20mg May be considered
42 1522 ACT Kit for Adults May be considered
43 1523 ACT Kit for (9-14 years)
May be considered after clarification of strength
for Artisunate is 150mg instead of 50mg
May not be
considered
44 1525 ACT Kit for (1-4 years) May be considered
45 1526 ACT Kit for (0-1 years) May be considered
46 1621 Cefixime Dispersible Tablets USP 100 mg May be considered
47 1625
Chloroquine Phosphate Syrup 50 mg / 5 ml in
60ml May be considered
48 1627 Clotrimazole Cream 2% IP 15gms Tube-Cream May be considered
49 1629 Fluconazole Tablets IP 200mg May be considered
50 1637 Lactulose Solution 3.325gm/5ml in 100ml bottle May be consideredPage 68 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
51 1643
Metronidazole benzoate Oral Suspention IP
100mg/5ml in 60ml May be considered
52 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
53 1650 Permethrin Cream 5% 30gms tube May be considered
54 1653 Povidone Iodine Ointment USP IP 5%, 100gm May be considered
55 1665 Glycerin IP 450gm
May be considered after submission of Re-Packing
product license for 500gm i.e.25B
May not be
considered
56 1669 Betahistine Tablets IP 8 mg May be considered56 1669 Betahistine Tablets IP 8 mg May be considered
57 1678 Methyl Cobalamin Tablets 500mcg May be considered
58 1690
Carbmazepine Suspension USP 100mg/5ml, in
100ml May be considered
59 1691 Aciclovir Tablets IP 400 mg May be considered
60 1699 Azithromycin Dispersible Tablet 100 Mg May be considered
61 1701
Paracetamol Syrup IP (Non Alcohol based) 125 mg
/ 5 ml in 60ml May be considered
62 1702 Ofloxacin Suspension 50 mg /5 ml , 60 ml May be considered
63 1705 Alprazolam Tablets IP 0.5 mg May be considered
64 1734 Allopurinol Tablets IP 100 mg May be considered
65 1739 Atorvastatin Tablets IP 20mg May be considered
66 1754
Chlorbutol+ Bezoncaine+ Turpentine Oil+
Paradichloro Benzine Ear Drops
May be considered after submission of latest valid
product license
May not be
considered
67 1794 Escitalopram Tablets 10mg May be considered
68 1808 Flunarazine Tablets 5mg May be considered
69 1846 Ivermectin Tablets USP 3mg May be consideredPage 69 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
70 1855 Levamisole Tablets IP 150mg May be considered
71 1865 Mefenamic Acid Tablets BP 500 mg May be considered
72 1903 Olanzapine Tablets 5 mg May be considered
73 1930 Ramipril Tablets IP 5mg May be considered
74 1953 Sodium valporate Tablets IP 200mg May be considered
75 1959 Tacrolimus Capsules 1mg May be considered75 1959 Tacrolimus Capsules 1mg May be considered
76 1971 Trimetazidine Tablets 20mg May be considered
77 2062 Acetyl Salicylic acid Tablets IP 75mg May be considered
78 2065 Atorvastatin Tablets IP 10mg May be considered
79 2069 Carbmazepine Tablets 200mg May be considered
80 2073 Citicoline Tab 500mg May be considered
81 2080 Diclofenac Sodium Tablets 100mg SR
May be considered after submission of latest valid
product license
May not be
considered
82 2111 Levothyroxine Tablets 50mcg May be considered
83 2113 Montelukast Tab 10mg May be considered
84 2125 Prazosin Tab 5mg May be considered
85 2140 Sodium Valporate Tab 500mg May be considered
86 2205 Amitriptyline Tablets 25mg May be considered
87 2217 Betahistine Tablets IP 16 mg May be considered
Page 70 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
88 2225
Calcium Citrate 1000 mg+ Vit. D3 200 I.U.
Methylcobalamin 500 mcg+ Folic Acid 5mg +
Pyridoxine Hcl 10 mg
May be considered after submission of latest valid
product license
May not be
considered
89 2235
Cefixime oral suspension 100mg / 5ml in 60ml
Bottle May be considered
90 2238 Chlordiazepoxide Tablets 25mg May be considered
91 2243 Clindamycin 1 % gel 30 gms May be considered
92 2258 Deflozocort Tablets 6mg May be considered
93 2271 Donepezil Tablets 5mg May be considered
94 2292 Flunarizine Tablets 10mg May be considered
95 2293 Fluoxetine Capsule 20mg May be considered
96 2297 Gabapentin Tablets 300mg May be considered
97 2313 Isosorbide Dinitrate Tablets 10mg May be considered
98 2316 Itraconazole Capsule 100 mg May be considered
99 2317 Ivermectin Tablets USP 6mg May be considered
100 2325 Levofloxacin Tablet 500 mg May be considered
101 2327 Levothyroxine Tablets 25mcg May be considered
102 2333 Liquid Paraffin 100 ml
May be considered after submission of Re-Packing
license in Form-25B
May not be
considered
103 2335 Liquid Paraffin 500ml
May be considered after submission of Re-Packing
license in Form-25B
May not be
considered
104 2337 Lorazepam Tablet 2mg May be considered
105 2343 Methyl Prednisolone IP 4mg Tablet
May be considered after submission of latest valid
product license
May not be
considered
Page 71 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
106 2344 Methyl Prednisolone IP 8mg Tablet
May be considered after submission of latest valid
product license
May not be
considered
107 2366 Oint.Salicylic Acid IP 12.0% w/w 50 grms tube May be considered
108 2367 Oint.Salicylic Acid IP 6.0% w/w 30 grms tube May be considered
109 2368 Olanzapine Tablets 2.5mg May be considered
110 2385
Polyethylene glycon with elecrolytes for oral
solution 137.15 gms powder May be considered
111 2397 Quetiapine 25mg Tablet May be considered111 2397 Quetiapine 25mg Tablet May be considered
112 2398 Quetiapine 50mg Tablet May be considered
113 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
114 2420
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Tube of 15 gms
May be considered after submission of latest valid
product license
May not be
considered
115 2429 Spironolactone Tablets IP 50 mg May be considered
116 2492 Sodium bicarbonateTab 500mg May be considered
97UNIMARCK
HEALTHCARE LIMITED
1 40 Ascorbic Acid Tablets IP (Chewable) 500 mg May be considered
May be considered after obating clarification from
Firm Remarks: May be Considered
2 207 Diltiazem Tablets IP 30 mg
May be considered after obating clarification from
the firm as tender called for ondansetron tablets
IP 4mg only
May not be
considered
3 279 Folic Acid Tablets 5mg May be considered
4 525 Paracetamol Tablets IP 500 mg May be considered
5 1134 Risperidone Tablets USP 2 mg May be considered
Page 72 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
6 1215 Dicyclomine Hcl Injection IP 10mg/ml in 2ml amp May be considered
7 1317 Ondansetron Tablets IP 4 mg
May be considered after clarification regarding the
formulation
May not be
considered
8 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
9 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered
10 1678 Methyl Cobalamin Tablets 500mcg May be considered
11 1705 Alprazolam Tablets IP 0.5 mg May be considered11 1705 Alprazolam Tablets IP 0.5 mg May be considered
12 1739 Atorvastatin Tablets IP 20mg May be considered
13 1754
Chlorbutol+ Bezoncaine+ Turpentine Oil+
Paradichloro Benzine Ear Drops May be considered
14 1791 Drotaverine Injection 40mg/2ml in 2 ml amp May be considered
15 1794 Escitalopram Tablets 10mg May be considered
16 1903 Olanzapine Tablets 5 mg
May be considered after submission of latest valid
product license.
May not be
considered
17 1930 Ramipril Tablets IP 5mg May be considered
18 2065 Atorvastatin Tablets IP 10mg May be considered
19 2073 Citicoline Tab 500mg May be considered
20 2080 Diclofenac Sodium Tablets 100mg SR May be considered
21 2113 Montelukast Tab 10mg May be considered
22 2126 Pregabalin SR Tablet 75mg May be considered
23 2127
Pregabalin SR 75mg + Methylcobalamin 1500mcg
Tablets May be considered
24 2205 Amitriptyline Tablets 25mg May be consideredPage 73 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
25 2217 Betahistine Tablets IP 16 mg May be considered
26 2258 Deflozocort Tablets 6mg May be considered
27 2271 Donepezil Tablets 5mg May be considered
28 2281 Escitalopram Tablets 5mg May be considered
29 2297 Gabapentin Tablets 300mg May be considered
30 2316 Itraconazole Capsule 100 mg May be considered30 2316 Itraconazole Capsule 100 mg May be considered
31 2319
Ketorolac Tromethamine Injection 30mg /ml, 1 ml
Ampoule May be considered
32 2320 Labetolol Hydrochloride Tablet IP 100mg May be considered
33 2325 Levofloxacin Tablet 500 mg May be considered
34 2326 Levofloxacin Tablet 750 mg May be considered
35 2340 Memantine 10mg Tablet May be considered
36 2352
Natural Progesterone Injection 100mg/2 ml 2ml
Ampule May be considered
37 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial
May be considered after submission of latest valid
product license.
May not be
considered
38 2368 Olanzapine Tablets 2.5mg
May be considered after submission of latest valid
product license.
May not be
considered
39 2398 Quetiapine 50mg Tablet May be considered
40 2412 Rosuvastatin Calcium 20 mg Tablet May be considered
41 2483 CilnidipineTab 20mg
May be considered after submission of latest valid
product license.
May not be
considered
98
Vee Excel Drugs and
Pharmaceuticals
Private Ltd
Firm Remarks: May be Considered
Page 74 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
1 197
Diclofenac Sodium 50mg Tablets IP (Enteric coated
Tablets) May be considered
2 251 Enalapril Maleate Tablets IP 5mg May be considered
3 1145 Carbimazole Tablets 5mg May be considered
4 1254 Spironolactone Tablets IP 25 mg, May be considered
5 1319 Pantaprazole (Enteric Coated) Tablets 40mg May be considered
6 1338
Clopidogrel Bisulphate Tablets I.P. 75mg,(Film
coated) May be considered6 1338 coated) May be considered
7 1621 Cefixime Dispersible Tablets USP 100 mg May be considered
8 1699 Azithromycin Dispersible Tablet 100 Mg
May be considered after submission of valid
product license
May not be
considered
9 1739 Atorvastatin Tablets IP 20mg May be considered
10 1953 Sodium valporate Tablets IP 200mg Submitted Export product License
May not be
considered
11 1971 Trimetazidine Tablets 20mg May be considered
12 2065 Atorvastatin Tablets IP 10mg May be considered
13 2113 Montelukast Tab 10mg May be considered
14 2140 Sodium Valporate Tab 500mg
May be considered after submission of valid
product license
May not be
considered
15 2146 Carbimazole Tablets 20mg May be considered
16 2235
Cefixime oral suspension 100mg / 5ml in 60ml
Bottle May be considered
17 2316 Itraconazole Capsule 100 mg May be considered
18 2325 Levofloxacin Tablet 500 mg May be considered
19 2326 Levofloxacin Tablet 750 mg May be consideredPage 75 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
20 2437 Trypsin and Chymotrypsin Tablets 10 mg
May be considered after clarification of product
licnese for 1,00,000 Armous units where as
tender called for 10mg
May not be
considered
99VERVE HUMAN CARE
LABORATORIES
1 1804 Fentanyl Inj. 100mcg/2ml May be considered
2 1890 Naloxone HCL Injection USP 400mcg/ml, 1ml amp May be considered
3 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules May be considered
Firm Remarks: May be Considered
3 2364 Noradrenaline Injection 1mg/ml, 2ml ampoules May be considered
4 2379 Pethidine Hydrochloride Injection BP 50mg/ ml May be considered
100vins bio products
limited
1 632 Antisnake Venom Injection May be considered
101Virchow Biotech
Private Limited
1 1820 Human Immunoglobulin IV 5 gm/100ml May be considered
102 Vivimed Labs Limited
1 192 Doxycycline HCL Capsule IP 100 mg May be considered
2 475
Miconazole Nitrate Cream IP 2% 30gm tube -
Cream May be considered
Firm Remarks: May be Considered
Firm Remarks: May be considered after submission of valid NCC Certificate (Not older then 6 months) and submit Manufacturing
capacity in Annexure-VIII
Firm Remarks: May be Considered
2 475 Cream May be considered
3 1151
Domperidone Suspension IP 1 mg / ml in 30ml
bottle May not be considered as the strength differ
May not be
considered
4 1372 Tropicamide+ phenylephrine 5 ml Eye drops
May be considered after clarification of volume of
vial/package/final container
May not be
considered
5 1377 Flurbiprofen Eye drops BP 0.03% 5 ml May be considered
6 1431 Gatifloxacin eye Drops 0.3 w/v in 5ml vial
May be considered after clarification of volume of
vial/package/final container
May not be
considered
Page 76 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
7 1454 Xylometazoline Nasal Drops 0.1% w/v 10 ml
May be considered after clarification of volume of
vial/package/final container
May not be
considered
8 1754
Chlorbutol+ Bezoncaine+ Turpentine Oil+
Paradichloro Benzine Ear Drops May be considered
9 2125 Prazosin Tab 5mg May be considered
10 2225
Calcium Citrate 1000 mg+ Vit. D3 200 I.U.
Methylcobalamin 500 mcg+ Folic Acid 5mg +
Pyridoxine Hcl 10 mg May be considered
11 2304
Hydroxy Propyl Methyl Cellulose Eye Drops 0.3%
in 10 ml
May be considered after clarification of volume of
vial/package/final container
May not be
considered
May be considered after clarification of volume of May not be
12 2353 Nepafenac 0.1%w/v Eye Drops , 5ml Vial
May be considered after clarification of volume of
vial/package/final container
May not be
considered
13 2419
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Bottle of 15 ml
May be considered after clarification of volume of
vial/package/final container
May not be
considered
14 2420
Sertaconazole Nitrate BP 2% w/v Propylene Glycol
base q.s. Pack -Tube of 15 gms
May be considered after clarification of volume of
vial/package/final container
May not be
considered
103 ZEST PHARM
1 8
Amoxicillin oral suspension IP 125 mg / 5 ml in
60ml May be considered
2 40 Ascorbic Acid Tablets IP (Chewable) 500 mg May be considered
3 97
Cotrimaxazole Tabs. IP 160mg+800mg
(Trimethoprim+Sulphamethoxazole ) May be considered
4 192 Doxycycline HCL Capsule IP 100 mg May be considered
Firm Remarks: May be considered after submission of Authorization letter nominating a responsible person (Authorization is given to
a firm i.e Royal agencies instead of a person, further authorization given by authorized signature)
5 1317 Ondansetron Tablets IP 4 mg May be considered
6 1522 ACT Kit for Adults May be considered
7 1647 Ondansetron Syrup IP 2mg/5ml in 30 ml bottle May be considered
8 1739 Atorvastatin Tablets IP 20mg May be considered
9 2065 Atorvastatin Tablets IP 10mg May be considered
Page 77 of 78
S No FirmsItem
CodeSpecification Item Remarks Status
10 2235
Cefixime oral suspension 100mg / 5ml in 60ml
Bottle May be considered
11 2326 Levofloxacin Tablet 750 mg May be considered
Note: All the bidders are here by requested to verify the Provisional Technical Evaluation Report and submit their supporting documents on or
before 12.00 P.M on 17.08.2020 to the email: [email protected] with Subject : Reply to T No 60(General Medicines) Preliminary TEC Report
Page 78 of 78